data_2mm6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mm6 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.861 0.363 . . . . 74.22 110.829 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.5 ptt-85 -104.73 155.09 37.99 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.578 0.704 . . . . 75.04 110.913 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -168.14 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.754 2.302 . . . . 64.53 112.31 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -80.83 -170.6 2.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 74.32 110.955 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.79 30.31 14.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 74.32 112.526 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.35 160.22 24.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.348 . . . . 73.51 110.926 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -88.56 127.31 35.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 65.34 110.855 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.593 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.4 p -137.54 161.91 35.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 73.34 110.912 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -156.42 -41.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 63.44 110.849 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.03 153.63 4.28 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 74.52 112.494 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.3 p -101.18 -35.65 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.814 0.34 . . . . 74.42 111.136 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.4 pp -77.69 -34.84 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 72.33 111.128 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -132.51 137.47 47.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 75.42 110.906 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -174.86 -169.01 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 71.22 110.916 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 66.0 m -49.78 147.69 3.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 64.2 110.84 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.97 -166.46 1.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 65.21 110.937 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.454 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -103.09 164.53 15.32 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.605 0.717 . . . . 61.31 110.849 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.454 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.0 Cg_endo -69.85 -12.89 12.5 Favored 'Cis proline' 0 C--O 1.232 0.194 0 C-N-CA 122.675 -1.802 . . . . 75.32 112.294 0.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -43.69 154.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 70.2 110.908 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -150.1 130.53 13.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 72.13 110.797 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 97.9 m -70.83 114.22 8.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 64.41 110.856 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.9 m -120.81 117.23 31.19 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 121.614 0.721 . . . . 72.41 111.158 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 168.83 65.96 Favored 'Cis proline' 0 C--N 1.341 0.143 0 C-N-CA 122.717 -1.785 . . . . 71.34 112.304 -0.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -7.58 21.4 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.706 2.271 . . . . 71.44 112.351 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.64 -45.51 8.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 72.25 110.883 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.2 tt -177.46 127.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 72.42 111.137 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.8 -124.81 1.18 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.783 -0.722 . . . . 65.11 112.517 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.0 mm -116.62 155.53 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.897 0.379 . . . . 70.14 111.161 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.593 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 64.3 m -91.84 132.03 36.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 71.33 110.871 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 75.32 110.903 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.839 0.352 . . . . 71.4 110.852 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -104.12 152.7 39.19 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.596 0.712 . . . . 73.41 110.864 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -168.57 0.28 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.681 2.254 . . . . 62.31 112.349 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -78.56 -170.18 1.99 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 74.2 110.954 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.85 29.43 13.48 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.792 -0.718 . . . . 52.22 112.467 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.12 157.83 29.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.868 0.366 . . . . 75.32 110.921 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.42 126.82 33.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.063 -0.517 . . . . 74.3 110.856 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 2.3 p -144.83 162.43 36.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 63.14 110.901 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -160.37 -41.62 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 73.24 110.881 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.48 162.56 1.46 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.742 -0.742 . . . . 73.53 112.529 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.19 -37.62 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.763 0.316 . . . . 73.32 111.111 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.8 pp -68.99 -24.43 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 74.13 111.127 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -151.29 137.59 18.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 71.15 110.881 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -174.1 -168.7 0.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.118 -0.492 . . . . 71.43 110.885 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 95.6 m -50.67 146.19 5.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 73.34 110.864 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -85.92 -168.07 2.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 74.32 110.909 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.453 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -100.03 164.6 16.12 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.643 0.735 . . . . 71.43 110.874 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.453 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.2 Cg_endo -69.81 -13.21 12.46 Favored 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.672 -1.803 . . . . 72.31 112.385 0.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -45.29 155.02 0.14 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 75.52 110.938 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -150.33 129.35 12.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.068 -0.514 . . . . 72.43 110.824 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 87.9 m -69.5 109.08 4.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 74.15 110.843 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.471 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 99.5 m -123.69 125.43 25.97 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.582 0.706 . . . . 70.13 111.174 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.471 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.1 Cg_endo -69.78 155.58 93.23 Favored 'Cis proline' 0 C--N 1.342 0.223 0 C-N-CA 122.655 -1.81 . . . . 72.53 112.361 -0.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 67.97 1.73 Allowed 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.726 2.284 . . . . 75.42 112.302 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.8 -34.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 74.23 110.882 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 tp 179.87 115.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.235 -0.439 . . . . 74.11 111.159 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.03 -125.84 1.37 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.713 -0.756 . . . . 75.32 112.435 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.9 mm -121.1 159.03 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.872 0.367 . . . . 74.2 111.151 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 75.0 m -95.63 136.45 36.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 65.35 110.886 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 74.0 110.928 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.86 0.362 . . . . 72.4 110.786 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -106.46 158.09 33.48 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.633 0.73 . . . . 74.15 110.819 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 -168.87 0.29 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.695 2.263 . . . . 72.11 112.377 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -80.37 -169.33 2.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 74.2 110.892 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.6 27.38 18.52 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.747 -0.74 . . . . 74.01 112.486 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -119.29 154.01 34.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.862 0.363 . . . . 73.34 110.91 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.79 142.27 28.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.491 . . . . 74.13 110.807 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.62 161.83 38.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 62.01 110.949 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -150.8 -41.46 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 75.21 110.892 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.4 170.5 0.32 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.812 -0.709 . . . . 44.35 112.453 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 p -112.31 -39.56 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 72.41 111.145 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.9 mp -61.95 -70.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 73.14 111.175 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -126.21 147.26 49.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 73.03 110.93 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -162.94 -76.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 74.35 110.844 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.1 m -121.76 143.15 49.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 73.42 110.92 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.69 -169.93 1.92 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 74.13 110.925 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.46 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -106.89 164.69 14.3 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.563 0.697 . . . . 71.22 110.914 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.87 -11.66 12.17 Favored 'Cis proline' 0 C--O 1.232 0.175 0 C-N-CA 122.634 -1.819 . . . . 74.41 112.353 0.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -42.38 151.95 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 75.4 110.876 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -150.53 132.72 15.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.021 -0.536 . . . . 75.33 110.865 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.1 m -69.54 112.96 6.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 71.12 110.891 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.4 m -121.56 117.05 30.33 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.603 0.716 . . . . 74.52 111.129 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 169.34 63.86 Favored 'Cis proline' 0 C--N 1.342 0.205 0 C-N-CA 122.627 -1.822 . . . . 73.33 112.363 -0.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.75 -7.21 20.48 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.692 2.261 . . . . 61.22 112.325 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -94.01 -53.22 4.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.268 -0.424 . . . . 72.53 110.93 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.6 tt -165.33 125.07 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 74.0 111.183 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.41 -124.97 1.12 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.817 -0.706 . . . . 73.42 112.527 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.15 170.19 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.88 0.372 . . . . 74.45 111.109 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 66.4 m -100.13 130.38 46.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 71.02 110.955 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 75.34 110.938 -179.942 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.813 0.339 . . . . 74.1 110.933 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -105.24 153.34 39.67 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.597 0.713 . . . . 75.44 110.847 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -169.08 0.31 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.688 2.259 . . . . 73.45 112.311 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -78.83 -170.64 2.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 74.34 110.9 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 50.23 28.55 13.86 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.708 -0.758 . . . . 55.53 112.497 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.58 155.26 34.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.855 0.359 . . . . 75.54 110.888 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -83.6 124.39 30.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 74.33 110.904 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.8 p -135.12 153.82 51.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 73.04 110.937 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -167.25 125.48 1.29 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 72.4 110.887 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.2 -133.18 6.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.655 -0.784 . . . . 71.53 112.486 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.6 p -169.53 -37.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.809 0.338 . . . . 64.24 111.171 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.1 tt -51.93 -44.97 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 75.1 111.127 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.56 152.95 31.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 60.25 110.825 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -174.34 -167.09 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 74.44 110.965 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 96.8 m -49.62 146.45 4.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.303 -0.408 . . . . 74.51 110.853 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.25 -167.9 2.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.31 110.87 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.456 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -99.68 164.7 16.06 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.573 0.701 . . . . 74.23 110.823 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.456 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.0 Cg_endo -69.65 -13.31 12.16 Favored 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.712 -1.787 . . . . 75.23 112.391 -0.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -45.46 155.22 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 74.42 110.898 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -150.21 129.66 12.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 64.44 110.909 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 67.2 m -70.03 111.38 5.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 73.35 110.945 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.455 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 80.4 m -122.62 124.11 26.8 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.604 0.716 . . . . 52.42 111.121 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.455 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.6 Cg_endo -69.72 157.63 91.76 Favored 'Cis proline' 0 C--N 1.342 0.189 0 C-N-CA 122.701 -1.791 . . . . 65.02 112.368 -0.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 64.04 1.79 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.722 2.282 . . . . 75.33 112.337 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -175.83 -36.09 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 73.35 110.882 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.3 tt -178.43 116.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.266 -0.425 . . . . 74.24 111.144 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.61 -126.68 1.46 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.795 -0.717 . . . . 55.52 112.545 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.8 mm -117.62 159.32 17.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.875 0.369 . . . . 72.31 111.122 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 78.1 m -96.38 134.03 40.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 73.03 110.912 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 73.32 110.931 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.811 0.339 . . . . 74.51 110.95 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.78 157.58 33.62 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.59 0.71 . . . . 75.42 110.868 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -168.58 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.692 2.261 . . . . 74.4 112.31 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -80.0 -170.82 2.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 74.14 110.932 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 50.87 27.9 14.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.781 -0.723 . . . . 75.4 112.466 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -120.24 153.08 36.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.836 0.351 . . . . 75.42 110.907 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.77 137.99 35.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.505 . . . . 73.42 110.897 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.1 p -150.75 155.88 40.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 72.25 110.867 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.73 117.78 4.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 71.13 110.859 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.05 -130.61 5.38 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.695 -0.764 . . . . 65.43 112.474 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -176.81 -35.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 75.51 111.082 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.69 -26.59 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 71.24 111.094 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -179.74 133.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 74.52 110.866 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.49 -77.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 73.32 110.922 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.3 m -120.85 149.15 43.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 74.22 110.873 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.23 -169.29 2.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 74.11 110.809 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.457 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -106.7 164.54 14.65 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.611 0.719 . . . . 54.01 110.858 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.457 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.66 -11.92 11.85 Favored 'Cis proline' 0 C--N 1.342 0.21 0 C-N-CA 122.71 -1.787 . . . . 73.13 112.356 -0.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -42.26 152.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 75.0 110.898 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -150.72 130.51 13.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 72.12 110.863 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 60.2 m -70.54 114.69 8.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 74.42 110.819 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.45 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 98.4 m -123.84 123.36 26.24 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.539 0.685 . . . . 74.02 111.182 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.81 158.07 91.55 Favored 'Cis proline' 0 C--N 1.341 0.163 0 C-N-CA 122.627 -1.822 . . . . 73.3 112.358 0.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 64.44 1.79 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.706 2.27 . . . . 74.33 112.297 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -177.2 -34.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 74.42 110.861 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 tt -176.88 107.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 75.22 111.16 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 176.46 -132.31 2.05 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.661 -0.78 . . . . 74.42 112.442 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.1 mm -116.06 158.87 16.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.869 0.366 . . . . 65.1 111.162 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 79.3 m -90.6 132.46 35.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 55.22 110.898 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 71.43 110.885 -179.964 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.785 0.326 . . . . 73.12 110.907 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -110.46 157.96 36.74 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.598 0.713 . . . . 73.31 110.907 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -167.14 0.21 Allowed 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.734 2.289 . . . . 72.35 112.351 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -82.03 178.23 8.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 52.34 110.945 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.33 13.25 53.83 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.689 -0.767 . . . . 74.02 112.514 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -101.82 172.76 6.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.875 0.369 . . . . 74.21 110.942 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.22 125.86 43.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 70.04 110.954 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.96 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.2 p -132.94 168.62 18.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 61.3 110.901 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -157.2 -42.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 73.04 110.812 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.81 173.1 0.88 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.827 -0.702 . . . . 65.42 112.459 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.6 m -121.29 -7.64 9.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.874 0.369 . . . . 75.52 111.11 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.2 pp -115.73 -24.29 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 72.25 111.147 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.45 120.4 7.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 72.22 110.86 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -163.07 -78.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 63.42 110.883 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.8 m -122.45 134.11 54.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 73.42 110.858 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.07 -177.08 2.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 75.11 110.892 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.465 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -101.38 165.05 14.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.655 0.741 . . . . 73.24 110.823 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.465 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.9 Cg_endo -69.75 -12.09 12.06 Favored 'Cis proline' 0 C--N 1.342 0.217 0 C-N-CA 122.693 -1.794 . . . . 74.33 112.362 0.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -47.73 159.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 72.34 110.931 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -143.95 -169.98 3.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.507 . . . . 74.34 110.899 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.521 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 44.9 m -125.1 119.09 27.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 64.11 110.84 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.455 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 88.5 m -129.19 124.17 22.07 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.564 0.697 . . . . 73.43 111.14 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.455 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.74 159.53 89.47 Favored 'Cis proline' 0 C--O 1.232 0.193 0 C-N-CA 122.68 -1.8 . . . . 74.12 112.341 -0.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 63.74 1.82 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.678 2.252 . . . . 74.03 112.338 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -175.48 -39.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 70.22 110.916 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.4 tt -177.97 127.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 73.53 111.075 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.03 -124.65 1.55 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.732 -0.747 . . . . 64.34 112.438 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.2 mm -114.81 152.39 16.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 73.12 111.205 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.96 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 71.6 m -93.4 158.83 15.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 73.15 110.876 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 73.24 110.928 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 16' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.789 0.328 . . . . 55.54 110.86 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -107.18 161.58 22.49 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.581 0.705 . . . . 75.35 110.933 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.74 -91.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.681 2.254 . . . . 72.41 112.31 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.402 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 6.5 p90 -155.15 -166.95 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 73.23 110.902 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.63 24.09 11.46 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.791 -0.718 . . . . 65.4 112.531 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -116.01 150.91 36.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.85 0.357 . . . . 75.54 110.953 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.65 138.2 36.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 73.45 110.862 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 p -144.31 161.88 37.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 74.14 110.923 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -154.99 -41.66 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 71.2 110.832 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.41 150.79 19.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 64.14 112.525 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.4 p -94.33 -31.45 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.767 0.317 . . . . 72.35 111.088 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.4 mp -63.88 -69.18 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 75.13 111.167 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -129.83 151.66 50.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 74.03 110.829 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.91 -76.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 72.13 110.927 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.2 m -123.01 149.23 44.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.443 . . . . 72.2 110.829 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -87.24 -168.38 2.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.489 . . . . 73.22 110.864 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.464 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -107.98 164.07 15.57 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.56 0.695 . . . . 73.54 110.893 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.464 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.76 -11.12 11.8 Favored 'Cis proline' 0 C--N 1.341 0.172 0 C-N-CA 122.676 -1.802 . . . . 72.42 112.363 0.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -41.69 152.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 74.52 110.899 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -151.35 129.19 11.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 75.21 110.901 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.45 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 36.3 m -70.62 114.61 8.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 75.01 110.868 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.0 m -119.25 118.98 32.23 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.562 0.696 . . . . 75.13 111.115 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.73 168.66 66.57 Favored 'Cis proline' 0 C--N 1.341 0.177 0 C-N-CA 122.676 -1.802 . . . . 72.13 112.406 -0.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -7.57 21.38 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.699 2.266 . . . . 75.53 112.375 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.58 -44.74 8.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 75.04 111.006 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.6 tt -174.6 123.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 63.42 111.127 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.42 -131.57 2.11 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.69 -0.767 . . . . 53.4 112.5 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.2 mt -113.26 158.53 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 72.31 111.097 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.45 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 80.8 m -90.81 130.82 36.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 73.15 110.888 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 74.32 110.898 179.998 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.844 0.354 . . . . 72.21 110.883 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -95.52 150.42 37.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.579 0.704 . . . . 73.53 110.858 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.81 -166.22 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.677 2.251 . . . . 72.43 112.334 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -80.97 176.23 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 75.01 110.969 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.09 7.78 57.31 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.751 -0.738 . . . . 73.34 112.5 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.34 -172.93 2.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 74.32 110.906 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -114.37 135.12 54.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 74.54 110.881 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 1.034 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -136.79 171.07 15.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 75.5 110.841 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -160.29 -42.4 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 73.12 110.884 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.03 153.6 50.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.686 -0.769 . . . . 73.43 112.518 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.8 p -90.93 -34.44 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.884 0.373 . . . . 73.12 111.15 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.3 pp -87.95 -25.41 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 74.25 111.084 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -128.27 113.18 15.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 71.13 110.879 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -174.25 -168.22 0.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 63.15 110.905 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 74.6 m -48.02 147.31 2.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 73.15 110.889 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.77 -167.62 1.73 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 74.53 110.873 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.477 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -100.41 163.44 18.21 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.654 0.74 . . . . 75.42 110.859 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.477 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.75 -12.17 12.1 Favored 'Cis proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.715 -1.785 . . . . 61.42 112.364 -0.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -44.65 155.34 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 75.15 110.988 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -146.24 127.87 15.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 74.13 110.82 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.536 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 55.5 m -60.53 122.67 15.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 71.42 110.888 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.9 t -121.51 116.22 30.76 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.578 0.704 . . . . 73.1 111.129 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 168.23 68.47 Favored 'Cis proline' 0 C--N 1.342 0.213 0 C-N-CA 122.644 -1.815 . . . . 63.34 112.382 -0.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 63.28 1.76 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.679 2.253 . . . . 75.42 112.356 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -174.69 -67.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.424 . . . . 73.31 110.927 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.7 tt -149.75 141.92 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 74.43 111.139 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.9 -112.89 0.98 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.723 -0.751 . . . . 74.45 112.548 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.33 -172.91 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 74.5 111.146 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 1.034 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 41.3 m -136.58 150.51 48.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 64.1 110.887 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 74.53 110.884 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.822 0.344 . . . . 63.24 110.869 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -109.77 157.71 36.86 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.696 0.76 . . . . 73.12 110.81 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -166.87 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.659 2.239 . . . . 75.33 112.36 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -85.45 179.25 7.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 71.24 110.944 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.94 12.33 54.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.689 -0.767 . . . . 70.15 112.449 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.84 168.73 8.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.93 0.395 . . . . 74.52 110.893 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.05 146.96 23.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.07 -0.514 . . . . 74.41 110.766 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.828 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -150.16 156.45 41.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 61.25 110.878 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -141.6 -42.16 0.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 74.05 110.9 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.05 -179.6 0.41 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.688 -0.768 . . . . 74.14 112.493 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.8 p -128.29 -39.42 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 63.32 111.125 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.84 -25.77 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 73.54 111.119 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.01 132.22 8.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 74.12 110.92 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -165.07 -76.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 74.14 110.949 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 m -120.87 134.33 55.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 63.23 110.893 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.99 -167.54 0.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 62.14 110.83 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.474 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -111.85 162.85 19.36 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.604 0.716 . . . . 75.05 110.858 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.474 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.73 -9.16 10.81 Favored 'Cis proline' 0 C--N 1.343 0.238 0 C-N-CA 122.674 -1.803 . . . . 73.13 112.327 -0.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -40.33 151.42 0.05 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.26 -0.427 . . . . 74.43 110.926 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -150.37 132.6 15.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 71.51 110.811 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.579 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 65.7 m -69.18 121.39 16.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 52.35 110.867 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.7 m -123.93 118.25 27.0 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.633 0.73 . . . . 72.53 111.091 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 164.05 80.44 Favored 'Cis proline' 0 C--N 1.342 0.202 0 C-N-CA 122.686 -1.797 . . . . 62.23 112.342 -0.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 63.09 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.648 2.232 . . . . 75.23 112.364 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -174.97 -68.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 75.02 110.95 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.8 mt -142.84 114.39 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 75.44 111.114 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.27 -128.84 1.82 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.71 -0.757 . . . . 72.32 112.447 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.5 -170.83 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.893 0.377 . . . . 74.44 111.134 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.828 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 58.1 m -130.47 149.63 52.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.472 . . . . 65.44 110.879 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.467 . . . . 64.34 110.851 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.841 0.353 . . . . 72.31 110.911 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -105.67 159.32 29.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.644 0.735 . . . . 74.42 110.848 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -90.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.707 2.272 . . . . 54.3 112.316 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -153.7 -164.5 1.9 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 75.14 110.998 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.34 27.13 15.55 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.697 -0.763 . . . . 74.41 112.481 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -125.34 155.09 40.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.892 0.377 . . . . 72.13 110.959 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -79.71 124.22 28.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 74.53 110.923 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.765 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.8 p -131.24 146.51 52.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 73.32 110.832 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -134.02 -44.54 0.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.103 -0.499 . . . . 75.01 110.878 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.53 149.83 7.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.796 -0.716 . . . . 75.33 112.501 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.13 -20.98 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 74.1 111.102 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.5 tt -115.86 -44.57 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 71.11 111.117 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.14 99.08 11.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 73.12 110.914 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -169.06 -167.06 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 72.02 110.912 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 80.5 m -49.77 133.18 21.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 72.41 110.823 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -79.03 -169.05 1.66 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 75.44 110.847 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.46 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -94.4 165.94 16.42 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.583 0.706 . . . . 73.22 110.838 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.73 -14.08 12.39 Favored 'Cis proline' 0 C--N 1.341 0.133 0 C-N-CA 122.682 -1.799 . . . . 71.22 112.4 -0.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -44.14 156.95 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 72.22 110.946 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -148.67 130.22 14.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 73.22 110.784 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.568 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 57.9 m -71.89 113.05 8.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.467 . . . . 61.21 110.902 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.9 m -119.38 118.33 32.5 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.551 0.691 . . . . 64.34 111.151 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.446 ' HD2' ' HA3' ' A' ' 27' ' ' GLY . 53.6 Cg_endo -69.76 170.44 58.48 Favored 'Cis proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.699 -1.792 . . . . 75.31 112.337 -0.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 -5.95 17.41 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.727 2.285 . . . . 71.14 112.381 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.6 -66.26 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 73.24 110.905 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.5 mt -151.72 128.1 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 71.22 111.119 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.446 ' HA3' ' HD2' ' A' ' 23' ' ' PRO . . . 166.32 -132.03 2.53 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.691 -0.766 . . . . 74.52 112.449 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.0 mm -110.35 167.32 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.872 0.368 . . . . 74.05 111.16 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.765 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 86.7 m -104.98 134.63 47.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 50.25 110.848 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 71.52 110.893 179.962 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.861 0.363 . . . . 74.22 110.829 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.5 ptt-85 -104.73 155.09 37.99 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.578 0.704 . . . . 75.04 110.913 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -168.14 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.754 2.302 . . . . 64.53 112.31 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -80.83 -170.6 2.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 74.32 110.955 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.79 30.31 14.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 74.32 112.526 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.35 160.22 24.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.348 . . . . 73.51 110.926 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -88.56 127.31 35.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 65.34 110.855 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.593 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.4 p -137.54 161.91 35.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 73.34 110.912 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -156.42 -41.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 63.44 110.849 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.03 153.63 4.28 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 74.52 112.494 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.3 p -101.18 -35.65 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.814 0.34 . . . . 74.42 111.136 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.4 pp -77.69 -34.84 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 72.33 111.128 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -132.51 137.47 47.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 75.42 110.906 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -174.86 -169.01 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 71.22 110.916 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 66.0 m -49.78 147.69 3.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 64.2 110.84 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.97 -166.46 1.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 65.21 110.937 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.454 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -103.09 164.53 15.32 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.605 0.717 . . . . 61.31 110.849 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.454 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.0 Cg_endo -69.85 -12.89 12.5 Favored 'Cis proline' 0 C--O 1.232 0.194 0 C-N-CA 122.675 -1.802 . . . . 75.32 112.294 0.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -43.69 154.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 70.2 110.908 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -150.1 130.53 13.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 72.13 110.797 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 97.9 m -70.83 114.22 8.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 64.41 110.856 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.9 m -120.81 117.23 31.19 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 121.614 0.721 . . . . 72.41 111.158 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 168.83 65.96 Favored 'Cis proline' 0 C--N 1.341 0.143 0 C-N-CA 122.717 -1.785 . . . . 71.34 112.304 -0.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -7.58 21.4 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.706 2.271 . . . . 71.44 112.351 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.64 -45.51 8.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 72.25 110.883 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.2 tt -177.46 127.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 72.42 111.137 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.8 -124.81 1.18 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.783 -0.722 . . . . 65.11 112.517 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.0 mm -116.62 155.53 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.897 0.379 . . . . 70.14 111.161 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.593 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 64.3 m -91.84 132.03 36.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 71.33 110.871 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 75.32 110.903 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.839 0.352 . . . . 71.4 110.852 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -104.12 152.7 39.19 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.596 0.712 . . . . 73.41 110.864 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -168.57 0.28 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.681 2.254 . . . . 62.31 112.349 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -78.56 -170.18 1.99 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 74.2 110.954 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.85 29.43 13.48 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.792 -0.718 . . . . 52.22 112.467 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.12 157.83 29.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.868 0.366 . . . . 75.32 110.921 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.42 126.82 33.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.063 -0.517 . . . . 74.3 110.856 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 2.3 p -144.83 162.43 36.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 63.14 110.901 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -160.37 -41.62 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 73.24 110.881 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.48 162.56 1.46 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.742 -0.742 . . . . 73.53 112.529 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.19 -37.62 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.763 0.316 . . . . 73.32 111.111 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.8 pp -68.99 -24.43 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 74.13 111.127 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -151.29 137.59 18.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 71.15 110.881 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -174.1 -168.7 0.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.118 -0.492 . . . . 71.43 110.885 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 95.6 m -50.67 146.19 5.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 73.34 110.864 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -85.92 -168.07 2.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 74.32 110.909 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.453 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -100.03 164.6 16.12 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.643 0.735 . . . . 71.43 110.874 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.453 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.2 Cg_endo -69.81 -13.21 12.46 Favored 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.672 -1.803 . . . . 72.31 112.385 0.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -45.29 155.02 0.14 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 75.52 110.938 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -150.33 129.35 12.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.068 -0.514 . . . . 72.43 110.824 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 87.9 m -69.5 109.08 4.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 74.15 110.843 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.471 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 99.5 m -123.69 125.43 25.97 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.582 0.706 . . . . 70.13 111.174 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.471 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.1 Cg_endo -69.78 155.58 93.23 Favored 'Cis proline' 0 C--N 1.342 0.223 0 C-N-CA 122.655 -1.81 . . . . 72.53 112.361 -0.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 67.97 1.73 Allowed 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.726 2.284 . . . . 75.42 112.302 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.8 -34.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 74.23 110.882 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 tp 179.87 115.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.235 -0.439 . . . . 74.11 111.159 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.03 -125.84 1.37 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.713 -0.756 . . . . 75.32 112.435 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.9 mm -121.1 159.03 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.872 0.367 . . . . 74.2 111.151 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 75.0 m -95.63 136.45 36.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 65.35 110.886 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 74.0 110.928 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.86 0.362 . . . . 72.4 110.786 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -106.46 158.09 33.48 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.633 0.73 . . . . 74.15 110.819 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 -168.87 0.29 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.695 2.263 . . . . 72.11 112.377 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -80.37 -169.33 2.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 74.2 110.892 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.6 27.38 18.52 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.747 -0.74 . . . . 74.01 112.486 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -119.29 154.01 34.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.862 0.363 . . . . 73.34 110.91 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.79 142.27 28.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.491 . . . . 74.13 110.807 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.62 161.83 38.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 62.01 110.949 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -150.8 -41.46 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 75.21 110.892 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.4 170.5 0.32 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.812 -0.709 . . . . 44.35 112.453 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 p -112.31 -39.56 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 72.41 111.145 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.9 mp -61.95 -70.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 73.14 111.175 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -126.21 147.26 49.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 73.03 110.93 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -162.94 -76.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 74.35 110.844 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.1 m -121.76 143.15 49.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 73.42 110.92 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.69 -169.93 1.92 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 74.13 110.925 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.46 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -106.89 164.69 14.3 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.563 0.697 . . . . 71.22 110.914 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.87 -11.66 12.17 Favored 'Cis proline' 0 C--O 1.232 0.175 0 C-N-CA 122.634 -1.819 . . . . 74.41 112.353 0.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -42.38 151.95 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 75.4 110.876 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -150.53 132.72 15.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.021 -0.536 . . . . 75.33 110.865 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.1 m -69.54 112.96 6.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 71.12 110.891 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.4 m -121.56 117.05 30.33 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.603 0.716 . . . . 74.52 111.129 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 169.34 63.86 Favored 'Cis proline' 0 C--N 1.342 0.205 0 C-N-CA 122.627 -1.822 . . . . 73.33 112.363 -0.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.75 -7.21 20.48 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.692 2.261 . . . . 61.22 112.325 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -94.01 -53.22 4.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.268 -0.424 . . . . 72.53 110.93 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.6 tt -165.33 125.07 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 74.0 111.183 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.41 -124.97 1.12 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.817 -0.706 . . . . 73.42 112.527 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.15 170.19 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.88 0.372 . . . . 74.45 111.109 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 66.4 m -100.13 130.38 46.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 71.02 110.955 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 75.34 110.938 -179.942 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.813 0.339 . . . . 74.1 110.933 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -105.24 153.34 39.67 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.597 0.713 . . . . 75.44 110.847 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -169.08 0.31 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.688 2.259 . . . . 73.45 112.311 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -78.83 -170.64 2.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 74.34 110.9 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 50.23 28.55 13.86 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.708 -0.758 . . . . 55.53 112.497 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.58 155.26 34.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.855 0.359 . . . . 75.54 110.888 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -83.6 124.39 30.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 74.33 110.904 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.8 p -135.12 153.82 51.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 73.04 110.937 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -167.25 125.48 1.29 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 72.4 110.887 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.2 -133.18 6.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.655 -0.784 . . . . 71.53 112.486 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.6 p -169.53 -37.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.809 0.338 . . . . 64.24 111.171 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.1 tt -51.93 -44.97 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 75.1 111.127 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.56 152.95 31.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 60.25 110.825 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -174.34 -167.09 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 74.44 110.965 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 96.8 m -49.62 146.45 4.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.303 -0.408 . . . . 74.51 110.853 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.25 -167.9 2.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.31 110.87 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.456 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -99.68 164.7 16.06 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.573 0.701 . . . . 74.23 110.823 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.456 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.0 Cg_endo -69.65 -13.31 12.16 Favored 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.712 -1.787 . . . . 75.23 112.391 -0.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -45.46 155.22 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 74.42 110.898 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -150.21 129.66 12.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 64.44 110.909 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 67.2 m -70.03 111.38 5.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 73.35 110.945 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.455 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 80.4 m -122.62 124.11 26.8 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.604 0.716 . . . . 52.42 111.121 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.455 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.6 Cg_endo -69.72 157.63 91.76 Favored 'Cis proline' 0 C--N 1.342 0.189 0 C-N-CA 122.701 -1.791 . . . . 65.02 112.368 -0.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 64.04 1.79 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.722 2.282 . . . . 75.33 112.337 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -175.83 -36.09 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 73.35 110.882 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.3 tt -178.43 116.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.266 -0.425 . . . . 74.24 111.144 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.61 -126.68 1.46 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.795 -0.717 . . . . 55.52 112.545 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.8 mm -117.62 159.32 17.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.875 0.369 . . . . 72.31 111.122 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 78.1 m -96.38 134.03 40.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 73.03 110.912 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 73.32 110.931 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.811 0.339 . . . . 74.51 110.95 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.78 157.58 33.62 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.59 0.71 . . . . 75.42 110.868 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -168.58 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.692 2.261 . . . . 74.4 112.31 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -80.0 -170.82 2.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 74.14 110.932 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 50.87 27.9 14.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.781 -0.723 . . . . 75.4 112.466 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -120.24 153.08 36.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.836 0.351 . . . . 75.42 110.907 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.77 137.99 35.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.505 . . . . 73.42 110.897 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.1 p -150.75 155.88 40.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 72.25 110.867 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.73 117.78 4.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 71.13 110.859 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.05 -130.61 5.38 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.695 -0.764 . . . . 65.43 112.474 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -176.81 -35.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 75.51 111.082 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.69 -26.59 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 71.24 111.094 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -179.74 133.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 74.52 110.866 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.49 -77.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 73.32 110.922 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.3 m -120.85 149.15 43.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 74.22 110.873 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.23 -169.29 2.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 74.11 110.809 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.457 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -106.7 164.54 14.65 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.611 0.719 . . . . 54.01 110.858 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.457 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.66 -11.92 11.85 Favored 'Cis proline' 0 C--N 1.342 0.21 0 C-N-CA 122.71 -1.787 . . . . 73.13 112.356 -0.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -42.26 152.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 75.0 110.898 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -150.72 130.51 13.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 72.12 110.863 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 60.2 m -70.54 114.69 8.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 74.42 110.819 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.45 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 98.4 m -123.84 123.36 26.24 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.539 0.685 . . . . 74.02 111.182 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.81 158.07 91.55 Favored 'Cis proline' 0 C--N 1.341 0.163 0 C-N-CA 122.627 -1.822 . . . . 73.3 112.358 0.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 64.44 1.79 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.706 2.27 . . . . 74.33 112.297 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -177.2 -34.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 74.42 110.861 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 tt -176.88 107.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 75.22 111.16 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 176.46 -132.31 2.05 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.661 -0.78 . . . . 74.42 112.442 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.1 mm -116.06 158.87 16.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.869 0.366 . . . . 65.1 111.162 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 79.3 m -90.6 132.46 35.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 55.22 110.898 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 71.43 110.885 -179.964 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.785 0.326 . . . . 73.12 110.907 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -110.46 157.96 36.74 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.598 0.713 . . . . 73.31 110.907 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -167.14 0.21 Allowed 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.734 2.289 . . . . 72.35 112.351 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -82.03 178.23 8.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 52.34 110.945 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.33 13.25 53.83 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.689 -0.767 . . . . 74.02 112.514 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -101.82 172.76 6.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.875 0.369 . . . . 74.21 110.942 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.22 125.86 43.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 70.04 110.954 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.96 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.2 p -132.94 168.62 18.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 61.3 110.901 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -157.2 -42.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 73.04 110.812 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.81 173.1 0.88 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.827 -0.702 . . . . 65.42 112.459 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.6 m -121.29 -7.64 9.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.874 0.369 . . . . 75.52 111.11 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.2 pp -115.73 -24.29 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 72.25 111.147 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.45 120.4 7.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 72.22 110.86 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -163.07 -78.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 63.42 110.883 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.8 m -122.45 134.11 54.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 73.42 110.858 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.07 -177.08 2.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 75.11 110.892 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.465 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -101.38 165.05 14.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.655 0.741 . . . . 73.24 110.823 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.465 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.9 Cg_endo -69.75 -12.09 12.06 Favored 'Cis proline' 0 C--N 1.342 0.217 0 C-N-CA 122.693 -1.794 . . . . 74.33 112.362 0.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -47.73 159.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 72.34 110.931 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -143.95 -169.98 3.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.507 . . . . 74.34 110.899 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.521 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 44.9 m -125.1 119.09 27.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 64.11 110.84 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.455 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 88.5 m -129.19 124.17 22.07 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.564 0.697 . . . . 73.43 111.14 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.455 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.74 159.53 89.47 Favored 'Cis proline' 0 C--O 1.232 0.193 0 C-N-CA 122.68 -1.8 . . . . 74.12 112.341 -0.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 63.74 1.82 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.678 2.252 . . . . 74.03 112.338 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -175.48 -39.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 70.22 110.916 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.4 tt -177.97 127.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 73.53 111.075 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.03 -124.65 1.55 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.732 -0.747 . . . . 64.34 112.438 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.2 mm -114.81 152.39 16.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 73.12 111.205 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.96 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 71.6 m -93.4 158.83 15.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 73.15 110.876 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 73.24 110.928 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 16' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.789 0.328 . . . . 55.54 110.86 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -107.18 161.58 22.49 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.581 0.705 . . . . 75.35 110.933 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.74 -91.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.681 2.254 . . . . 72.41 112.31 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.402 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 6.5 p90 -155.15 -166.95 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 73.23 110.902 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.63 24.09 11.46 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.791 -0.718 . . . . 65.4 112.531 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -116.01 150.91 36.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.85 0.357 . . . . 75.54 110.953 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.65 138.2 36.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 73.45 110.862 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 p -144.31 161.88 37.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 74.14 110.923 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -154.99 -41.66 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 71.2 110.832 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.41 150.79 19.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 64.14 112.525 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.4 p -94.33 -31.45 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.767 0.317 . . . . 72.35 111.088 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.4 mp -63.88 -69.18 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 75.13 111.167 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -129.83 151.66 50.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 74.03 110.829 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.91 -76.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 72.13 110.927 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.2 m -123.01 149.23 44.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.443 . . . . 72.2 110.829 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -87.24 -168.38 2.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.489 . . . . 73.22 110.864 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.464 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -107.98 164.07 15.57 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.56 0.695 . . . . 73.54 110.893 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.464 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.76 -11.12 11.8 Favored 'Cis proline' 0 C--N 1.341 0.172 0 C-N-CA 122.676 -1.802 . . . . 72.42 112.363 0.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -41.69 152.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 74.52 110.899 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -151.35 129.19 11.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 75.21 110.901 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.45 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 36.3 m -70.62 114.61 8.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 75.01 110.868 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.0 m -119.25 118.98 32.23 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.562 0.696 . . . . 75.13 111.115 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.73 168.66 66.57 Favored 'Cis proline' 0 C--N 1.341 0.177 0 C-N-CA 122.676 -1.802 . . . . 72.13 112.406 -0.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -7.57 21.38 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.699 2.266 . . . . 75.53 112.375 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.58 -44.74 8.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 75.04 111.006 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.6 tt -174.6 123.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 63.42 111.127 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.42 -131.57 2.11 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.69 -0.767 . . . . 53.4 112.5 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.2 mt -113.26 158.53 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 72.31 111.097 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.45 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 80.8 m -90.81 130.82 36.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 73.15 110.888 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 74.32 110.898 179.998 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.844 0.354 . . . . 72.21 110.883 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -95.52 150.42 37.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.579 0.704 . . . . 73.53 110.858 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.81 -166.22 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.677 2.251 . . . . 72.43 112.334 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -80.97 176.23 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 75.01 110.969 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.09 7.78 57.31 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.751 -0.738 . . . . 73.34 112.5 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.34 -172.93 2.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 74.32 110.906 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -114.37 135.12 54.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 74.54 110.881 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 1.034 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -136.79 171.07 15.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 75.5 110.841 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -160.29 -42.4 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 73.12 110.884 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.03 153.6 50.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.686 -0.769 . . . . 73.43 112.518 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.8 p -90.93 -34.44 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.884 0.373 . . . . 73.12 111.15 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.3 pp -87.95 -25.41 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 74.25 111.084 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -128.27 113.18 15.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 71.13 110.879 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -174.25 -168.22 0.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 63.15 110.905 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 74.6 m -48.02 147.31 2.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 73.15 110.889 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.77 -167.62 1.73 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 74.53 110.873 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.477 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -100.41 163.44 18.21 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.654 0.74 . . . . 75.42 110.859 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.477 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.75 -12.17 12.1 Favored 'Cis proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.715 -1.785 . . . . 61.42 112.364 -0.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -44.65 155.34 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 75.15 110.988 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -146.24 127.87 15.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 74.13 110.82 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.536 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 55.5 m -60.53 122.67 15.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 71.42 110.888 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.9 t -121.51 116.22 30.76 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.578 0.704 . . . . 73.1 111.129 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 168.23 68.47 Favored 'Cis proline' 0 C--N 1.342 0.213 0 C-N-CA 122.644 -1.815 . . . . 63.34 112.382 -0.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 63.28 1.76 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.679 2.253 . . . . 75.42 112.356 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -174.69 -67.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.424 . . . . 73.31 110.927 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.7 tt -149.75 141.92 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 74.43 111.139 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.9 -112.89 0.98 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.723 -0.751 . . . . 74.45 112.548 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.33 -172.91 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 74.5 111.146 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 1.034 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 41.3 m -136.58 150.51 48.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 64.1 110.887 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 74.53 110.884 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.822 0.344 . . . . 63.24 110.869 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -109.77 157.71 36.86 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.696 0.76 . . . . 73.12 110.81 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -166.87 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.659 2.239 . . . . 75.33 112.36 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -85.45 179.25 7.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 71.24 110.944 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.94 12.33 54.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.689 -0.767 . . . . 70.15 112.449 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.84 168.73 8.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.93 0.395 . . . . 74.52 110.893 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.05 146.96 23.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.07 -0.514 . . . . 74.41 110.766 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.828 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -150.16 156.45 41.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 61.25 110.878 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -141.6 -42.16 0.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 74.05 110.9 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.05 -179.6 0.41 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.688 -0.768 . . . . 74.14 112.493 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.8 p -128.29 -39.42 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 63.32 111.125 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.84 -25.77 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 73.54 111.119 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.01 132.22 8.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 74.12 110.92 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -165.07 -76.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 74.14 110.949 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 m -120.87 134.33 55.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 63.23 110.893 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.99 -167.54 0.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 62.14 110.83 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.474 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -111.85 162.85 19.36 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.604 0.716 . . . . 75.05 110.858 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.474 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.73 -9.16 10.81 Favored 'Cis proline' 0 C--N 1.343 0.238 0 C-N-CA 122.674 -1.803 . . . . 73.13 112.327 -0.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -40.33 151.42 0.05 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.26 -0.427 . . . . 74.43 110.926 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -150.37 132.6 15.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 71.51 110.811 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.579 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 65.7 m -69.18 121.39 16.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 52.35 110.867 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.7 m -123.93 118.25 27.0 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.633 0.73 . . . . 72.53 111.091 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 164.05 80.44 Favored 'Cis proline' 0 C--N 1.342 0.202 0 C-N-CA 122.686 -1.797 . . . . 62.23 112.342 -0.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 63.09 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.648 2.232 . . . . 75.23 112.364 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -174.97 -68.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 75.02 110.95 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.8 mt -142.84 114.39 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 75.44 111.114 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.27 -128.84 1.82 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.71 -0.757 . . . . 72.32 112.447 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.5 -170.83 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.893 0.377 . . . . 74.44 111.134 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.828 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 58.1 m -130.47 149.63 52.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.472 . . . . 65.44 110.879 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.467 . . . . 64.34 110.851 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.841 0.353 . . . . 72.31 110.911 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -105.67 159.32 29.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.644 0.735 . . . . 74.42 110.848 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -90.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.707 2.272 . . . . 54.3 112.316 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -153.7 -164.5 1.9 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 75.14 110.998 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.34 27.13 15.55 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.697 -0.763 . . . . 74.41 112.481 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -125.34 155.09 40.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.892 0.377 . . . . 72.13 110.959 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -79.71 124.22 28.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 74.53 110.923 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.765 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.8 p -131.24 146.51 52.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 73.32 110.832 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -134.02 -44.54 0.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.103 -0.499 . . . . 75.01 110.878 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.53 149.83 7.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.796 -0.716 . . . . 75.33 112.501 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.13 -20.98 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 74.1 111.102 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.5 tt -115.86 -44.57 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 71.11 111.117 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.14 99.08 11.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 73.12 110.914 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -169.06 -167.06 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 72.02 110.912 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 80.5 m -49.77 133.18 21.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 72.41 110.823 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -79.03 -169.05 1.66 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 75.44 110.847 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.46 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -94.4 165.94 16.42 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.583 0.706 . . . . 73.22 110.838 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.73 -14.08 12.39 Favored 'Cis proline' 0 C--N 1.341 0.133 0 C-N-CA 122.682 -1.799 . . . . 71.22 112.4 -0.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -44.14 156.95 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 72.22 110.946 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -148.67 130.22 14.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 73.22 110.784 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.568 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 57.9 m -71.89 113.05 8.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.467 . . . . 61.21 110.902 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.9 m -119.38 118.33 32.5 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.551 0.691 . . . . 64.34 111.151 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.446 ' HD2' ' HA3' ' A' ' 27' ' ' GLY . 53.6 Cg_endo -69.76 170.44 58.48 Favored 'Cis proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.699 -1.792 . . . . 75.31 112.337 -0.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 -5.95 17.41 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.727 2.285 . . . . 71.14 112.381 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.6 -66.26 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 73.24 110.905 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.5 mt -151.72 128.1 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 71.22 111.119 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.446 ' HA3' ' HD2' ' A' ' 23' ' ' PRO . . . 166.32 -132.03 2.53 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.691 -0.766 . . . . 74.52 112.449 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.0 mm -110.35 167.32 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.872 0.368 . . . . 74.05 111.16 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.765 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 86.7 m -104.98 134.63 47.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 50.25 110.848 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 71.52 110.893 179.962 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.861 0.363 . . . . 63.140000000000001 110.829 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.5 ptt-85 -104.73 155.09 37.99 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.578 0.704 . . . . 75.040000000000006 110.913 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -168.14 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.754 2.302 . . . . 61.240000000000002 112.31 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -80.83 -170.6 2.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 63.43 110.955 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.79 30.31 14.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 71.510000000000005 112.526 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.35 160.22 24.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.348 . . . . 62.530000000000001 110.926 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -88.56 127.31 35.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 64.109999999999999 110.855 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.593 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.4 p -137.54 161.91 35.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 55.409999999999997 110.912 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -156.42 -41.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 45.549999999999997 110.849 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.03 153.63 4.28 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 50.229999999999997 112.494 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.3 p -101.18 -35.65 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.814 0.34 . . . . 70.5 111.136 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.613 HD12 ' HB2' ' A' ' 13' ' ' ASN . 2.4 pp -77.69 -34.84 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 62.219999999999999 111.128 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.613 ' HB2' HD12 ' A' ' 12' ' ' ILE . 11.4 t30 -132.51 137.47 47.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 72.040000000000006 110.906 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -174.86 -169.01 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 70.5 110.916 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 66.0 m -49.78 147.69 3.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 64.200000000000003 110.84 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.97 -166.46 1.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 65.209999999999994 110.937 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.465 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -103.09 164.53 15.32 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.605 0.717 . . . . 61.310000000000002 110.849 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.465 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.0 Cg_endo -69.85 -12.89 12.5 Favored 'Cis proline' 0 C--O 1.232 0.194 0 C-N-CA 122.675 -1.802 . . . . 75.319999999999993 112.294 0.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -43.69 154.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 53.420000000000002 110.908 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -150.1 130.53 13.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 72.129999999999995 110.797 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 97.9 m -70.83 114.22 8.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 54.329999999999998 110.856 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.9 m -120.81 117.23 31.19 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 121.614 0.721 . . . . 55.119999999999997 111.158 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 168.83 65.96 Favored 'Cis proline' 0 C--N 1.341 0.143 0 C-N-CA 122.717 -1.785 . . . . 63.539999999999999 112.304 -0.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -7.58 21.4 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.706 2.271 . . . . 65.049999999999997 112.351 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -92.64 -45.51 8.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 71.420000000000002 110.883 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.2 tt -177.46 127.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 72.420000000000002 111.137 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.8 -124.81 1.18 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.783 -0.722 . . . . 43.539999999999999 112.517 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.0 mm -116.62 155.53 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.897 0.379 . . . . 55.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.617 ' O ' HD22 ' A' ' 30' ' ' LEU . 64.3 m -91.84 132.03 36.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 71.329999999999998 110.871 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.617 HD22 ' O ' ' A' ' 29' ' ' CYS . 3.4 mm? . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 51.310000000000002 110.903 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.839 0.352 . . . . 71.400000000000006 110.852 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -104.12 152.7 39.19 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.596 0.712 . . . . 73.109999999999999 110.864 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -168.57 0.28 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.681 2.254 . . . . 55.009999999999998 112.349 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -78.56 -170.18 1.99 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 72.040000000000006 110.954 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.85 29.43 13.48 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.792 -0.718 . . . . 52.219999999999999 112.467 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.12 157.83 29.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.868 0.366 . . . . 75.319999999999993 110.921 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.42 126.82 33.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.063 -0.517 . . . . 74.299999999999997 110.856 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 2.3 p -144.83 162.43 36.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 63.140000000000001 110.901 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.483 ' HB3' HD13 ' A' ' 26' ' ' ILE . 4.8 p-10 -160.37 -41.62 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 73.239999999999995 110.881 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.48 162.56 1.46 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.742 -0.742 . . . . 60.5 112.529 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.19 -37.62 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.763 0.316 . . . . 73.319999999999993 111.111 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.8 pp -68.99 -24.43 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 71.409999999999997 111.127 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -151.29 137.59 18.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 71.150000000000006 110.881 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -174.1 -168.7 0.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.118 -0.492 . . . . 64.329999999999998 110.885 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 95.6 m -50.67 146.19 5.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 73.340000000000003 110.864 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -85.92 -168.07 2.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 70.25 110.909 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.468 ' CB ' ' HA ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -100.03 164.6 16.12 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.643 0.735 . . . . 71.430000000000007 110.874 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.468 ' HA ' ' CB ' ' A' ' 17' ' ' ASP . 54.2 Cg_endo -69.81 -13.21 12.46 Favored 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.672 -1.803 . . . . 63.310000000000002 112.385 0.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -45.29 155.02 0.14 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 75.519999999999996 110.938 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -150.33 129.35 12.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.068 -0.514 . . . . 72.430000000000007 110.824 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 87.9 m -69.5 109.08 4.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 74.150000000000006 110.843 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.48 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 99.5 m -123.69 125.43 25.97 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.582 0.706 . . . . 70.129999999999995 111.174 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.1 Cg_endo -69.78 155.58 93.23 Favored 'Cis proline' 0 C--N 1.342 0.223 0 C-N-CA 122.655 -1.81 . . . . 64.530000000000001 112.361 -0.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 67.97 1.73 Allowed 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.726 2.284 . . . . 75.420000000000002 112.302 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.8 -34.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 74.230000000000004 110.882 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.483 HD13 ' HB3' ' A' ' 9' ' ' ASP . 4.5 tp 179.87 115.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.235 -0.439 . . . . 71.120000000000005 111.159 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.449 ' O ' HD13 ' A' ' 28' ' ' ILE . . . 167.03 -125.84 1.37 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.713 -0.756 . . . . 63.140000000000001 112.435 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 27' ' ' GLY . 11.9 mm -121.1 159.03 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.872 0.367 . . . . 74.200000000000003 111.151 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 75.0 m -95.63 136.45 36.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 65.349999999999994 110.886 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.595 HD22 ' O ' ' A' ' 29' ' ' CYS . 3.5 mm? . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 74.0 110.928 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.86 0.362 . . . . 54.32 110.786 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -106.46 158.09 33.48 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.633 0.73 . . . . 74.150000000000006 110.819 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 -168.87 0.29 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.695 2.263 . . . . 72.109999999999999 112.377 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.405 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 16.4 p90 -80.37 -169.33 2.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 71.310000000000002 110.892 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.6 27.38 18.52 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.747 -0.74 . . . . 72.329999999999998 112.486 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -119.29 154.01 34.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.862 0.363 . . . . 73.340000000000003 110.91 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.79 142.27 28.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.491 . . . . 70.420000000000002 110.807 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.62 161.83 38.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 54.200000000000003 110.949 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -150.8 -41.46 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 74.5 110.892 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.4 170.5 0.32 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.812 -0.709 . . . . 44.350000000000001 112.453 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 p -112.31 -39.56 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 72.409999999999997 111.145 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.443 HD12 ' H ' ' A' ' 12' ' ' ILE . 3.9 mp -61.95 -70.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 72.140000000000001 111.175 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -126.21 147.26 49.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 55.32 110.93 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -162.94 -76.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 74.349999999999994 110.844 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.1 m -121.76 143.15 49.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 73.420000000000002 110.92 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.69 -169.93 1.92 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 74.129999999999995 110.925 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.469 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -106.89 164.69 14.3 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.563 0.697 . . . . 71.219999999999999 110.914 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.469 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.87 -11.66 12.17 Favored 'Cis proline' 0 C--O 1.232 0.175 0 C-N-CA 122.634 -1.819 . . . . 73.530000000000001 112.353 0.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -42.38 151.95 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 75.400000000000006 110.876 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -150.53 132.72 15.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.021 -0.536 . . . . 75.329999999999998 110.865 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.1 m -69.54 112.96 6.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 71.120000000000005 110.891 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.4 m -121.56 117.05 30.33 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.603 0.716 . . . . 74.519999999999996 111.129 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 169.34 63.86 Favored 'Cis proline' 0 C--N 1.342 0.205 0 C-N-CA 122.627 -1.822 . . . . 73.329999999999998 112.363 -0.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.75 -7.21 20.48 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.692 2.261 . . . . 53.450000000000003 112.325 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -94.01 -53.22 4.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.268 -0.424 . . . . 62.149999999999999 110.93 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.6 tt -165.33 125.07 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 74.0 111.183 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.41 -124.97 1.12 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.817 -0.706 . . . . 73.230000000000004 112.527 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.15 170.19 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.88 0.372 . . . . 62.409999999999997 111.109 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.641 ' O ' HD22 ' A' ' 30' ' ' LEU . 66.4 m -100.13 130.38 46.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 65.140000000000001 110.955 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.641 HD22 ' O ' ' A' ' 29' ' ' CYS . 3.9 mm? . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 75.340000000000003 110.938 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.813 0.339 . . . . 72.200000000000003 110.933 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -105.24 153.34 39.67 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.597 0.713 . . . . 74.25 110.847 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -169.08 0.31 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.688 2.259 . . . . 73.439999999999998 112.311 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -78.83 -170.64 2.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 73.439999999999998 110.9 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 50.23 28.55 13.86 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.708 -0.758 . . . . 53.240000000000002 112.497 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.58 155.26 34.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.855 0.359 . . . . 75.540000000000006 110.888 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -83.6 124.39 30.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 74.329999999999998 110.904 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.8 p -135.12 153.82 51.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 71.099999999999994 110.937 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -167.25 125.48 1.29 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 72.400000000000006 110.887 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.2 -133.18 6.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.655 -0.784 . . . . 71.530000000000001 112.486 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.6 p -169.53 -37.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.809 0.338 . . . . 64.239999999999995 111.171 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.42 HG23 ' N ' ' A' ' 13' ' ' ASN . 5.1 tt -51.93 -44.97 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 72.329999999999998 111.127 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.42 ' N ' HG23 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -153.56 152.95 31.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 60.25 110.825 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -174.34 -167.09 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 74.439999999999998 110.965 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 96.8 m -49.62 146.45 4.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.303 -0.408 . . . . 74.510000000000005 110.853 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.25 -167.9 2.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.310000000000002 110.87 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.469 ' CB ' ' HA ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -99.68 164.7 16.06 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.573 0.701 . . . . 53.43 110.823 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.469 ' HA ' ' CB ' ' A' ' 17' ' ' ASP . 54.0 Cg_endo -69.65 -13.31 12.16 Favored 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.712 -1.787 . . . . 75.230000000000004 112.391 -0.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -45.46 155.22 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 74.420000000000002 110.898 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -150.21 129.66 12.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 64.439999999999998 110.909 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 67.2 m -70.03 111.38 5.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 73.349999999999994 110.945 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.467 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 80.4 m -122.62 124.11 26.8 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.604 0.716 . . . . 52.420000000000002 111.121 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.6 Cg_endo -69.72 157.63 91.76 Favored 'Cis proline' 0 C--N 1.342 0.189 0 C-N-CA 122.701 -1.791 . . . . 65.019999999999996 112.368 -0.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 64.04 1.79 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.722 2.282 . . . . 65.329999999999998 112.337 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -175.83 -36.09 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 64.140000000000001 110.882 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 26' ' ' ILE . 1.3 tt -178.43 116.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.266 -0.425 . . . . 74.239999999999995 111.144 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.61 -126.68 1.46 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.795 -0.717 . . . . 41.240000000000002 112.545 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 29' ' ' CYS . 10.8 mm -117.62 159.32 17.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.875 0.369 . . . . 55.439999999999998 111.122 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 78.1 m -96.38 134.03 40.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 61.43 110.912 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.594 HD22 ' O ' ' A' ' 29' ' ' CYS . 3.3 mm? . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 73.319999999999993 110.931 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.811 0.339 . . . . 74.510000000000005 110.95 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.78 157.58 33.62 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.59 0.71 . . . . 62.530000000000001 110.868 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -168.58 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.692 2.261 . . . . 74.200000000000003 112.31 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -80.0 -170.82 2.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 71.219999999999999 110.932 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 50.87 27.9 14.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.781 -0.723 . . . . 75.400000000000006 112.466 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -120.24 153.08 36.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.836 0.351 . . . . 75.120000000000005 110.907 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.77 137.99 35.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.505 . . . . 71.040000000000006 110.897 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.1 p -150.75 155.88 40.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 72.25 110.867 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.73 117.78 4.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 71.129999999999995 110.859 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.05 -130.61 5.38 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.695 -0.764 . . . . 30.120000000000001 112.474 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -176.81 -35.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 75.510000000000005 111.082 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.466 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -57.69 -26.59 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 70.510000000000005 111.094 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -179.74 133.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 74.519999999999996 110.866 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.49 -77.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 65.450000000000003 110.922 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.3 m -120.85 149.15 43.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 53.350000000000001 110.873 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.23 -169.29 2.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 74.109999999999999 110.809 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.468 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -106.7 164.54 14.65 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.611 0.719 . . . . 45.310000000000002 110.858 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.468 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.66 -11.92 11.85 Favored 'Cis proline' 0 C--N 1.342 0.21 0 C-N-CA 122.71 -1.787 . . . . 73.129999999999995 112.356 -0.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -42.26 152.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 65.129999999999995 110.898 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -150.72 130.51 13.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 72.120000000000005 110.863 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 60.2 m -70.54 114.69 8.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 74.420000000000002 110.819 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.463 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 98.4 m -123.84 123.36 26.24 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.539 0.685 . . . . 74.019999999999996 111.182 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.463 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.81 158.07 91.55 Favored 'Cis proline' 0 C--N 1.341 0.163 0 C-N-CA 122.627 -1.822 . . . . 72.409999999999997 112.358 0.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 64.44 1.79 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.706 2.27 . . . . 74.239999999999995 112.297 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -177.2 -34.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 74.420000000000002 110.861 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.455 ' O ' HG23 ' A' ' 26' ' ' ILE . 4.7 tt -176.88 107.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 72.420000000000002 111.16 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 176.46 -132.31 2.05 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.661 -0.78 . . . . 74.420000000000002 112.442 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 29' ' ' CYS . 12.1 mm -116.06 158.87 16.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.869 0.366 . . . . 51.210000000000001 111.162 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.625 ' O ' HD22 ' A' ' 30' ' ' LEU . 79.3 m -90.6 132.46 35.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 54.140000000000001 110.898 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.625 HD22 ' O ' ' A' ' 29' ' ' CYS . 3.7 mm? . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 65.030000000000001 110.885 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.785 0.326 . . . . 73.120000000000005 110.907 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -110.46 157.96 36.74 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.598 0.713 . . . . 73.310000000000002 110.907 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -167.14 0.21 Allowed 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.734 2.289 . . . . 65.439999999999998 112.351 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -82.03 178.23 8.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 52.340000000000003 110.945 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.33 13.25 53.83 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.689 -0.767 . . . . 74.019999999999996 112.514 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -101.82 172.76 6.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.875 0.369 . . . . 74.209999999999994 110.942 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.22 125.86 43.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 70.040000000000006 110.954 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.96 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.2 p -132.94 168.62 18.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 61.299999999999997 110.901 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -157.2 -42.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 73.040000000000006 110.812 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.81 173.1 0.88 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.827 -0.702 . . . . 65.420000000000002 112.459 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.6 m -121.29 -7.64 9.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.874 0.369 . . . . 64.019999999999996 111.11 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.2 pp -115.73 -24.29 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 52.310000000000002 111.147 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.45 120.4 7.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 72.219999999999999 110.86 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -163.07 -78.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 63.420000000000002 110.883 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.8 m -122.45 134.11 54.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 73.420000000000002 110.858 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.07 -177.08 2.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 75.109999999999999 110.892 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.481 ' CB ' ' HA ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -101.38 165.05 14.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.655 0.741 . . . . 73.239999999999995 110.823 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.481 ' HA ' ' CB ' ' A' ' 17' ' ' ASP . 53.9 Cg_endo -69.75 -12.09 12.06 Favored 'Cis proline' 0 C--N 1.342 0.217 0 C-N-CA 122.693 -1.794 . . . . 74.329999999999998 112.362 0.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -47.73 159.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 72.340000000000003 110.931 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -143.95 -169.98 3.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.507 . . . . 74.340000000000003 110.899 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.521 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 44.9 m -125.1 119.09 27.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 64.109999999999999 110.84 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.465 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 88.5 m -129.19 124.17 22.07 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.564 0.697 . . . . 70.109999999999999 111.14 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.465 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.74 159.53 89.47 Favored 'Cis proline' 0 C--O 1.232 0.193 0 C-N-CA 122.68 -1.8 . . . . 71.120000000000005 112.341 -0.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 63.74 1.82 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.678 2.252 . . . . 74.030000000000001 112.338 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.598 HD13 ' O ' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -175.48 -39.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 70.219999999999999 110.916 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.4 tt -177.97 127.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 73.530000000000001 111.075 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.03 -124.65 1.55 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.732 -0.747 . . . . 61.219999999999999 112.438 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.2 mm -114.81 152.39 16.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 73.120000000000005 111.205 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.96 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 71.6 m -93.4 158.83 15.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 73.150000000000006 110.876 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 63.240000000000002 110.928 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.789 0.328 . . . . 55.539999999999999 110.86 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -107.18 161.58 22.49 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.581 0.705 . . . . 75.349999999999994 110.933 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.74 -91.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.681 2.254 . . . . 72.409999999999997 112.31 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 6.5 p90 -155.15 -166.95 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 73.230000000000004 110.902 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.63 24.09 11.46 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.791 -0.718 . . . . 65.400000000000006 112.531 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -116.01 150.91 36.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.85 0.357 . . . . 75.099999999999994 110.953 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.65 138.2 36.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 73.450000000000003 110.862 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 p -144.31 161.88 37.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 74.140000000000001 110.923 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -154.99 -41.66 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 71.200000000000003 110.832 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.41 150.79 19.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 64.140000000000001 112.525 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.4 p -94.33 -31.45 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.767 0.317 . . . . 72.349999999999994 111.088 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.4 mp -63.88 -69.18 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 75.129999999999995 111.167 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -129.83 151.66 50.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 71.140000000000001 110.829 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.91 -76.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 72.129999999999995 110.927 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.2 m -123.01 149.23 44.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.443 . . . . 72.200000000000003 110.829 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.24 -168.38 2.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.489 . . . . 42.32 110.864 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.472 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -107.98 164.07 15.57 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.56 0.695 . . . . 73.540000000000006 110.893 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.472 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.76 -11.12 11.8 Favored 'Cis proline' 0 C--N 1.341 0.172 0 C-N-CA 122.676 -1.802 . . . . 72.420000000000002 112.363 0.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -41.69 152.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 74.519999999999996 110.899 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -151.35 129.19 11.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 75.209999999999994 110.901 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.45 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 36.3 m -70.62 114.61 8.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 75.010000000000005 110.868 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.406 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 68.0 m -119.25 118.98 32.23 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.562 0.696 . . . . 74.150000000000006 111.115 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.406 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.9 Cg_endo -69.73 168.66 66.57 Favored 'Cis proline' 0 C--N 1.341 0.177 0 C-N-CA 122.676 -1.802 . . . . 72.129999999999995 112.406 -0.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -7.57 21.38 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.699 2.266 . . . . 75.530000000000001 112.375 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.51 HD13 ' O ' ' A' ' 25' ' ' LEU . 0.9 OUTLIER -93.58 -44.74 8.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 51.409999999999997 111.006 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.404 HG23 ' O ' ' A' ' 26' ' ' ILE . 8.6 tt -174.6 123.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 61.219999999999999 111.127 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.42 -131.57 2.11 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.69 -0.767 . . . . 53.399999999999999 112.5 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 29' ' ' CYS . 12.2 mt -113.26 158.53 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 63.420000000000002 111.097 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.635 ' O ' HD22 ' A' ' 30' ' ' LEU . 80.8 m -90.81 130.82 36.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 73.150000000000006 110.888 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.635 HD22 ' O ' ' A' ' 29' ' ' CYS . 3.0 mm? . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 73.129999999999995 110.898 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.844 0.354 . . . . 72.209999999999994 110.883 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -95.52 150.42 37.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.579 0.704 . . . . 55.43 110.858 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.81 -166.22 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.677 2.251 . . . . 65.439999999999998 112.334 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -80.97 176.23 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 75.010000000000005 110.969 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.09 7.78 57.31 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.751 -0.738 . . . . 31.550000000000001 112.5 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.34 -172.93 2.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 74.319999999999993 110.906 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -114.37 135.12 54.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 74.540000000000006 110.881 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 1.034 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -136.79 171.07 15.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 75.5 110.841 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -160.29 -42.4 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 73.120000000000005 110.884 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.03 153.6 50.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.686 -0.769 . . . . 22.32 112.518 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.43 HG13 HG23 ' A' ' 12' ' ' ILE . 10.8 p -90.93 -34.44 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.884 0.373 . . . . 62.149999999999999 111.15 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.43 HG23 HG13 ' A' ' 11' ' ' VAL . 1.3 pp -87.95 -25.41 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 74.25 111.084 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -128.27 113.18 15.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 71.129999999999995 110.879 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -174.25 -168.22 0.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 61.210000000000001 110.905 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 74.6 m -48.02 147.31 2.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 73.150000000000006 110.889 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.77 -167.62 1.73 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 71.319999999999993 110.873 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -100.41 163.44 18.21 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.654 0.74 . . . . 75.420000000000002 110.859 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.75 -12.17 12.1 Favored 'Cis proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.715 -1.785 . . . . 61.420000000000002 112.364 -0.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -44.65 155.34 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 64.510000000000005 110.988 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -146.24 127.87 15.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 74.129999999999995 110.82 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.536 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 55.5 m -60.53 122.67 15.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 63.229999999999997 110.888 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 22' ' ' THR . 5.9 t -121.51 116.22 30.76 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.578 0.704 . . . . 64.329999999999998 111.129 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 168.23 68.47 Favored 'Cis proline' 0 C--N 1.342 0.213 0 C-N-CA 122.644 -1.815 . . . . 62.420000000000002 112.382 -0.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 63.28 1.76 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.679 2.253 . . . . 75.420000000000002 112.356 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.451 HD12 HG22 ' A' ' 26' ' ' ILE . 2.6 tm? -174.69 -67.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.424 . . . . 73.140000000000001 110.927 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.451 HG22 HD12 ' A' ' 25' ' ' LEU . 17.7 tt -149.75 141.92 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 74.219999999999999 111.139 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.419 ' C ' HD13 ' A' ' 28' ' ' ILE . . . 136.9 -112.89 0.98 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.723 -0.751 . . . . 74.450000000000003 112.548 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.498 HG22 ' H ' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -110.33 -172.91 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 70.430000000000007 111.146 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 1.034 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 41.3 m -136.58 150.51 48.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 64.099999999999994 110.887 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 74.530000000000001 110.884 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.822 0.344 . . . . 45.409999999999997 110.869 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -109.77 157.71 36.86 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.696 0.76 . . . . 62.43 110.81 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -166.87 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.659 2.239 . . . . 75.329999999999998 112.36 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -85.45 179.25 7.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 64.040000000000006 110.944 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.94 12.33 54.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.689 -0.767 . . . . 43.420000000000002 112.449 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.84 168.73 8.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.93 0.395 . . . . 74.519999999999996 110.893 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.05 146.96 23.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.07 -0.514 . . . . 64.319999999999993 110.766 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.828 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -150.16 156.45 41.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 51.520000000000003 110.878 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -141.6 -42.16 0.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 74.049999999999997 110.9 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.05 -179.6 0.41 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.688 -0.768 . . . . 51.149999999999999 112.493 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.8 p -128.29 -39.42 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 63.229999999999997 111.125 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.464 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -73.84 -25.77 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 73.540000000000006 111.119 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.01 132.22 8.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 74.120000000000005 110.92 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -165.07 -76.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 74.140000000000001 110.949 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 m -120.87 134.33 55.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 63.229999999999997 110.893 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.99 -167.54 0.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 44.340000000000003 110.83 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.484 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -111.85 162.85 19.36 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.604 0.716 . . . . 51.420000000000002 110.858 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.73 -9.16 10.81 Favored 'Cis proline' 0 C--N 1.343 0.238 0 C-N-CA 122.674 -1.803 . . . . 73.129999999999995 112.327 -0.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -40.33 151.42 0.05 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.26 -0.427 . . . . 72.5 110.926 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -150.37 132.6 15.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 71.510000000000005 110.811 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.579 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 65.7 m -69.18 121.39 16.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 52.350000000000001 110.867 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.412 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 54.7 m -123.93 118.25 27.0 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.633 0.73 . . . . 72.530000000000001 111.091 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.412 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.83 164.05 80.44 Favored 'Cis proline' 0 C--N 1.342 0.202 0 C-N-CA 122.686 -1.797 . . . . 61.509999999999998 112.342 -0.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 63.09 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.648 2.232 . . . . 73.420000000000002 112.364 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.591 HD13 HG13 ' A' ' 26' ' ' ILE . 2.0 tm? -174.97 -68.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 61.530000000000001 110.95 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.591 HG13 HD13 ' A' ' 25' ' ' LEU . 27.8 mt -142.84 114.39 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 75.439999999999998 111.114 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.27 -128.84 1.82 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.71 -0.757 . . . . 72.319999999999993 112.447 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.4 HG22 ' H ' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -106.5 -170.83 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.893 0.377 . . . . 74.439999999999998 111.134 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.828 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 58.1 m -130.47 149.63 52.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.472 . . . . 65.439999999999998 110.879 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.467 . . . . 64.340000000000003 110.851 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.841 0.353 . . . . 72.310000000000002 110.911 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -105.67 159.32 29.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.644 0.735 . . . . 74.420000000000002 110.848 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -90.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.707 2.272 . . . . 53.229999999999997 112.316 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.42 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 17.0 p90 -153.7 -164.5 1.9 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 75.140000000000001 110.998 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.34 27.13 15.55 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.697 -0.763 . . . . 74.409999999999997 112.481 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -125.34 155.09 40.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.892 0.377 . . . . 72.129999999999995 110.959 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -79.71 124.22 28.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 63.439999999999998 110.923 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.765 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.8 p -131.24 146.51 52.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 65.540000000000006 110.832 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -134.02 -44.54 0.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.103 -0.499 . . . . 74.209999999999994 110.878 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.53 149.83 7.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.796 -0.716 . . . . 74.109999999999999 112.501 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.13 -20.98 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 61.43 111.102 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 13' ' ' ASN . 5.5 tt -115.86 -44.57 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 70.230000000000004 111.117 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.425 ' N ' HG23 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -92.14 99.08 11.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 73.120000000000005 110.914 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -169.06 -167.06 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 72.019999999999996 110.912 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 80.5 m -49.77 133.18 21.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 72.409999999999997 110.823 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -79.03 -169.05 1.66 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 75.439999999999998 110.847 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.498 ' CB ' ' HA ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -94.4 165.94 16.42 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.583 0.706 . . . . 73.219999999999999 110.838 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.498 ' HA ' ' CB ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.73 -14.08 12.39 Favored 'Cis proline' 0 C--N 1.341 0.133 0 C-N-CA 122.682 -1.799 . . . . 60.210000000000001 112.4 -0.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -44.14 156.95 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 72.219999999999999 110.946 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -148.67 130.22 14.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 73.219999999999999 110.784 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.568 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 57.9 m -71.89 113.05 8.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.467 . . . . 54.009999999999998 110.902 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.411 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 66.9 m -119.38 118.33 32.5 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.551 0.691 . . . . 64.340000000000003 111.151 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.462 ' HD2' ' HA3' ' A' ' 27' ' ' GLY . 53.6 Cg_endo -69.76 170.44 58.48 Favored 'Cis proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.699 -1.792 . . . . 75.310000000000002 112.337 -0.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 -5.95 17.41 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.727 2.285 . . . . 70.010000000000005 112.381 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.6 -66.26 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 53.32 110.905 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.5 mt -151.72 128.1 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 60.520000000000003 111.119 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.462 ' HA3' ' HD2' ' A' ' 23' ' ' PRO . . . 166.32 -132.03 2.53 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.691 -0.766 . . . . 74.519999999999996 112.449 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.485 HG22 ' H ' ' A' ' 29' ' ' CYS . 3.0 mm -110.35 167.32 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.872 0.368 . . . . 74.049999999999997 111.16 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.765 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 86.7 m -104.98 134.63 47.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 50.25 110.848 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.625 HD22 ' O ' ' A' ' 29' ' ' CYS . 2.5 mm? . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 63.109999999999999 110.893 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.861 0.363 . . . . 63.140000000000001 110.829 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.5 ptt-85 -104.73 155.09 37.99 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.578 0.704 . . . . 75.040000000000006 110.913 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -168.14 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.754 2.302 . . . . 61.240000000000002 112.31 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -80.83 -170.6 2.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 63.43 110.955 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.79 30.31 14.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 71.510000000000005 112.526 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.35 160.22 24.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.348 . . . . 62.530000000000001 110.926 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -88.56 127.31 35.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 64.109999999999999 110.855 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.593 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.4 p -137.54 161.91 35.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 55.409999999999997 110.912 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -156.42 -41.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 45.549999999999997 110.849 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.03 153.63 4.28 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 50.229999999999997 112.494 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.3 p -101.18 -35.65 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.814 0.34 . . . . 70.5 111.136 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.613 HD12 ' HB2' ' A' ' 13' ' ' ASN . 2.4 pp -77.69 -34.84 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 62.219999999999999 111.128 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.613 ' HB2' HD12 ' A' ' 12' ' ' ILE . 11.4 t30 -132.51 137.47 47.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 72.040000000000006 110.906 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -174.86 -169.01 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 70.5 110.916 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 66.0 m -49.78 147.69 3.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 64.200000000000003 110.84 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.97 -166.46 1.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 65.209999999999994 110.937 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.465 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -103.09 164.53 15.32 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.605 0.717 . . . . 61.310000000000002 110.849 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.465 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.0 Cg_endo -69.85 -12.89 12.5 Favored 'Cis proline' 0 C--O 1.232 0.194 0 C-N-CA 122.675 -1.802 . . . . 75.319999999999993 112.294 0.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -43.69 154.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 53.420000000000002 110.908 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -150.1 130.53 13.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 72.129999999999995 110.797 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 97.9 m -70.83 114.22 8.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 54.329999999999998 110.856 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.9 m -120.81 117.23 31.19 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 121.614 0.721 . . . . 55.119999999999997 111.158 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 168.83 65.96 Favored 'Cis proline' 0 C--N 1.341 0.143 0 C-N-CA 122.717 -1.785 . . . . 63.539999999999999 112.304 -0.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -7.58 21.4 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.706 2.271 . . . . 65.049999999999997 112.351 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -92.64 -45.51 8.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 71.420000000000002 110.883 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.2 tt -177.46 127.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 72.420000000000002 111.137 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.8 -124.81 1.18 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.783 -0.722 . . . . 43.539999999999999 112.517 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.0 mm -116.62 155.53 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.897 0.379 . . . . 55.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.617 ' O ' HD22 ' A' ' 30' ' ' LEU . 64.3 m -91.84 132.03 36.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 71.329999999999998 110.871 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.617 HD22 ' O ' ' A' ' 29' ' ' CYS . 3.4 mm? . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 51.310000000000002 110.903 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.839 0.352 . . . . 71.400000000000006 110.852 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -104.12 152.7 39.19 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.596 0.712 . . . . 73.109999999999999 110.864 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -168.57 0.28 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.681 2.254 . . . . 55.009999999999998 112.349 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -78.56 -170.18 1.99 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 72.040000000000006 110.954 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.85 29.43 13.48 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.792 -0.718 . . . . 52.219999999999999 112.467 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.12 157.83 29.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.868 0.366 . . . . 75.319999999999993 110.921 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.42 126.82 33.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.063 -0.517 . . . . 74.299999999999997 110.856 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 2.3 p -144.83 162.43 36.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 63.140000000000001 110.901 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.483 ' HB3' HD13 ' A' ' 26' ' ' ILE . 4.8 p-10 -160.37 -41.62 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 73.239999999999995 110.881 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.48 162.56 1.46 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.742 -0.742 . . . . 60.5 112.529 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.19 -37.62 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.763 0.316 . . . . 73.319999999999993 111.111 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.8 pp -68.99 -24.43 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 71.409999999999997 111.127 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -151.29 137.59 18.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 71.150000000000006 110.881 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -174.1 -168.7 0.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.118 -0.492 . . . . 64.329999999999998 110.885 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 95.6 m -50.67 146.19 5.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 73.340000000000003 110.864 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -85.92 -168.07 2.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 70.25 110.909 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.468 ' CB ' ' HA ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -100.03 164.6 16.12 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.643 0.735 . . . . 71.430000000000007 110.874 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.468 ' HA ' ' CB ' ' A' ' 17' ' ' ASP . 54.2 Cg_endo -69.81 -13.21 12.46 Favored 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.672 -1.803 . . . . 63.310000000000002 112.385 0.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -45.29 155.02 0.14 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 75.519999999999996 110.938 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -150.33 129.35 12.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.068 -0.514 . . . . 72.430000000000007 110.824 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 87.9 m -69.5 109.08 4.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 74.150000000000006 110.843 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.48 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 99.5 m -123.69 125.43 25.97 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.582 0.706 . . . . 70.129999999999995 111.174 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.1 Cg_endo -69.78 155.58 93.23 Favored 'Cis proline' 0 C--N 1.342 0.223 0 C-N-CA 122.655 -1.81 . . . . 64.530000000000001 112.361 -0.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 67.97 1.73 Allowed 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.726 2.284 . . . . 75.420000000000002 112.302 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.8 -34.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 74.230000000000004 110.882 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.483 HD13 ' HB3' ' A' ' 9' ' ' ASP . 4.5 tp 179.87 115.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.235 -0.439 . . . . 71.120000000000005 111.159 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.449 ' O ' HD13 ' A' ' 28' ' ' ILE . . . 167.03 -125.84 1.37 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.713 -0.756 . . . . 63.140000000000001 112.435 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 27' ' ' GLY . 11.9 mm -121.1 159.03 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.872 0.367 . . . . 74.200000000000003 111.151 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 75.0 m -95.63 136.45 36.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 65.349999999999994 110.886 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.595 HD22 ' O ' ' A' ' 29' ' ' CYS . 3.5 mm? . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 74.0 110.928 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.86 0.362 . . . . 54.32 110.786 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -106.46 158.09 33.48 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.633 0.73 . . . . 74.150000000000006 110.819 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 -168.87 0.29 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.695 2.263 . . . . 72.109999999999999 112.377 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.405 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 16.4 p90 -80.37 -169.33 2.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 71.310000000000002 110.892 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.6 27.38 18.52 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.747 -0.74 . . . . 72.329999999999998 112.486 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -119.29 154.01 34.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.862 0.363 . . . . 73.340000000000003 110.91 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.79 142.27 28.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.491 . . . . 70.420000000000002 110.807 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.62 161.83 38.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 54.200000000000003 110.949 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -150.8 -41.46 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 74.5 110.892 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.4 170.5 0.32 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.812 -0.709 . . . . 44.350000000000001 112.453 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 p -112.31 -39.56 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 72.409999999999997 111.145 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.443 HD12 ' H ' ' A' ' 12' ' ' ILE . 3.9 mp -61.95 -70.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 72.140000000000001 111.175 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -126.21 147.26 49.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 55.32 110.93 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -162.94 -76.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 74.349999999999994 110.844 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.1 m -121.76 143.15 49.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 73.420000000000002 110.92 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.69 -169.93 1.92 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 74.129999999999995 110.925 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.469 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -106.89 164.69 14.3 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.563 0.697 . . . . 71.219999999999999 110.914 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.469 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.87 -11.66 12.17 Favored 'Cis proline' 0 C--O 1.232 0.175 0 C-N-CA 122.634 -1.819 . . . . 73.530000000000001 112.353 0.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -42.38 151.95 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 75.400000000000006 110.876 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -150.53 132.72 15.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.021 -0.536 . . . . 75.329999999999998 110.865 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.1 m -69.54 112.96 6.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 71.120000000000005 110.891 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.4 m -121.56 117.05 30.33 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.603 0.716 . . . . 74.519999999999996 111.129 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 169.34 63.86 Favored 'Cis proline' 0 C--N 1.342 0.205 0 C-N-CA 122.627 -1.822 . . . . 73.329999999999998 112.363 -0.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.75 -7.21 20.48 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.692 2.261 . . . . 53.450000000000003 112.325 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -94.01 -53.22 4.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.268 -0.424 . . . . 62.149999999999999 110.93 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.6 tt -165.33 125.07 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 74.0 111.183 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.41 -124.97 1.12 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.817 -0.706 . . . . 73.230000000000004 112.527 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.15 170.19 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.88 0.372 . . . . 62.409999999999997 111.109 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.641 ' O ' HD22 ' A' ' 30' ' ' LEU . 66.4 m -100.13 130.38 46.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 65.140000000000001 110.955 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.641 HD22 ' O ' ' A' ' 29' ' ' CYS . 3.9 mm? . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 75.340000000000003 110.938 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.813 0.339 . . . . 72.200000000000003 110.933 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -105.24 153.34 39.67 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.597 0.713 . . . . 74.25 110.847 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -169.08 0.31 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.688 2.259 . . . . 73.439999999999998 112.311 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -78.83 -170.64 2.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 73.439999999999998 110.9 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 50.23 28.55 13.86 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.708 -0.758 . . . . 53.240000000000002 112.497 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.58 155.26 34.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.855 0.359 . . . . 75.540000000000006 110.888 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -83.6 124.39 30.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 74.329999999999998 110.904 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.8 p -135.12 153.82 51.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 71.099999999999994 110.937 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -167.25 125.48 1.29 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 72.400000000000006 110.887 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.2 -133.18 6.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.655 -0.784 . . . . 71.530000000000001 112.486 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.6 p -169.53 -37.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.809 0.338 . . . . 64.239999999999995 111.171 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.42 HG23 ' N ' ' A' ' 13' ' ' ASN . 5.1 tt -51.93 -44.97 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 72.329999999999998 111.127 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.42 ' N ' HG23 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -153.56 152.95 31.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 60.25 110.825 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -174.34 -167.09 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 74.439999999999998 110.965 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 96.8 m -49.62 146.45 4.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.303 -0.408 . . . . 74.510000000000005 110.853 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.25 -167.9 2.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.310000000000002 110.87 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.469 ' CB ' ' HA ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -99.68 164.7 16.06 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.573 0.701 . . . . 53.43 110.823 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.469 ' HA ' ' CB ' ' A' ' 17' ' ' ASP . 54.0 Cg_endo -69.65 -13.31 12.16 Favored 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.712 -1.787 . . . . 75.230000000000004 112.391 -0.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -45.46 155.22 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 74.420000000000002 110.898 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -150.21 129.66 12.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 64.439999999999998 110.909 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 67.2 m -70.03 111.38 5.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 73.349999999999994 110.945 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.467 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 80.4 m -122.62 124.11 26.8 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.604 0.716 . . . . 52.420000000000002 111.121 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.6 Cg_endo -69.72 157.63 91.76 Favored 'Cis proline' 0 C--N 1.342 0.189 0 C-N-CA 122.701 -1.791 . . . . 65.019999999999996 112.368 -0.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 64.04 1.79 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.722 2.282 . . . . 65.329999999999998 112.337 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -175.83 -36.09 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 64.140000000000001 110.882 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 26' ' ' ILE . 1.3 tt -178.43 116.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.266 -0.425 . . . . 74.239999999999995 111.144 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.61 -126.68 1.46 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.795 -0.717 . . . . 41.240000000000002 112.545 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 29' ' ' CYS . 10.8 mm -117.62 159.32 17.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.875 0.369 . . . . 55.439999999999998 111.122 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 78.1 m -96.38 134.03 40.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 61.43 110.912 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.594 HD22 ' O ' ' A' ' 29' ' ' CYS . 3.3 mm? . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 73.319999999999993 110.931 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.811 0.339 . . . . 74.510000000000005 110.95 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.78 157.58 33.62 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.59 0.71 . . . . 62.530000000000001 110.868 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -168.58 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.692 2.261 . . . . 74.200000000000003 112.31 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -80.0 -170.82 2.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 71.219999999999999 110.932 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 50.87 27.9 14.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.781 -0.723 . . . . 75.400000000000006 112.466 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -120.24 153.08 36.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.836 0.351 . . . . 75.120000000000005 110.907 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.77 137.99 35.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.505 . . . . 71.040000000000006 110.897 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.1 p -150.75 155.88 40.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 72.25 110.867 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.73 117.78 4.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 71.129999999999995 110.859 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.05 -130.61 5.38 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.695 -0.764 . . . . 30.120000000000001 112.474 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -176.81 -35.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 75.510000000000005 111.082 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.466 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -57.69 -26.59 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 70.510000000000005 111.094 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -179.74 133.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 74.519999999999996 110.866 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.49 -77.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 65.450000000000003 110.922 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.3 m -120.85 149.15 43.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 53.350000000000001 110.873 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.23 -169.29 2.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 74.109999999999999 110.809 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.468 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -106.7 164.54 14.65 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.611 0.719 . . . . 45.310000000000002 110.858 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.468 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.66 -11.92 11.85 Favored 'Cis proline' 0 C--N 1.342 0.21 0 C-N-CA 122.71 -1.787 . . . . 73.129999999999995 112.356 -0.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -42.26 152.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 65.129999999999995 110.898 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -150.72 130.51 13.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 72.120000000000005 110.863 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 60.2 m -70.54 114.69 8.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 74.420000000000002 110.819 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.463 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 98.4 m -123.84 123.36 26.24 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.539 0.685 . . . . 74.019999999999996 111.182 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.463 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.81 158.07 91.55 Favored 'Cis proline' 0 C--N 1.341 0.163 0 C-N-CA 122.627 -1.822 . . . . 72.409999999999997 112.358 0.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 64.44 1.79 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.706 2.27 . . . . 74.239999999999995 112.297 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -177.2 -34.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 74.420000000000002 110.861 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.455 ' O ' HG23 ' A' ' 26' ' ' ILE . 4.7 tt -176.88 107.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 72.420000000000002 111.16 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 176.46 -132.31 2.05 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.661 -0.78 . . . . 74.420000000000002 112.442 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 29' ' ' CYS . 12.1 mm -116.06 158.87 16.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.869 0.366 . . . . 51.210000000000001 111.162 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.625 ' O ' HD22 ' A' ' 30' ' ' LEU . 79.3 m -90.6 132.46 35.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 54.140000000000001 110.898 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.625 HD22 ' O ' ' A' ' 29' ' ' CYS . 3.7 mm? . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 65.030000000000001 110.885 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.785 0.326 . . . . 73.120000000000005 110.907 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -110.46 157.96 36.74 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.598 0.713 . . . . 73.310000000000002 110.907 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -167.14 0.21 Allowed 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.734 2.289 . . . . 65.439999999999998 112.351 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -82.03 178.23 8.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 52.340000000000003 110.945 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.33 13.25 53.83 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.689 -0.767 . . . . 74.019999999999996 112.514 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -101.82 172.76 6.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.875 0.369 . . . . 74.209999999999994 110.942 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.22 125.86 43.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 70.040000000000006 110.954 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.96 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.2 p -132.94 168.62 18.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 61.299999999999997 110.901 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -157.2 -42.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 73.040000000000006 110.812 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.81 173.1 0.88 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.827 -0.702 . . . . 65.420000000000002 112.459 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.6 m -121.29 -7.64 9.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.874 0.369 . . . . 64.019999999999996 111.11 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.2 pp -115.73 -24.29 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 52.310000000000002 111.147 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.45 120.4 7.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 72.219999999999999 110.86 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -163.07 -78.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 63.420000000000002 110.883 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.8 m -122.45 134.11 54.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 73.420000000000002 110.858 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.07 -177.08 2.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 75.109999999999999 110.892 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.481 ' CB ' ' HA ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -101.38 165.05 14.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.655 0.741 . . . . 73.239999999999995 110.823 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.481 ' HA ' ' CB ' ' A' ' 17' ' ' ASP . 53.9 Cg_endo -69.75 -12.09 12.06 Favored 'Cis proline' 0 C--N 1.342 0.217 0 C-N-CA 122.693 -1.794 . . . . 74.329999999999998 112.362 0.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -47.73 159.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 72.340000000000003 110.931 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -143.95 -169.98 3.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.507 . . . . 74.340000000000003 110.899 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.521 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 44.9 m -125.1 119.09 27.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 64.109999999999999 110.84 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.465 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 88.5 m -129.19 124.17 22.07 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.564 0.697 . . . . 70.109999999999999 111.14 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.465 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.74 159.53 89.47 Favored 'Cis proline' 0 C--O 1.232 0.193 0 C-N-CA 122.68 -1.8 . . . . 71.120000000000005 112.341 -0.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 63.74 1.82 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.678 2.252 . . . . 74.030000000000001 112.338 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.598 HD13 ' O ' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -175.48 -39.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 70.219999999999999 110.916 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.4 tt -177.97 127.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 73.530000000000001 111.075 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.03 -124.65 1.55 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.732 -0.747 . . . . 61.219999999999999 112.438 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.2 mm -114.81 152.39 16.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 73.120000000000005 111.205 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.96 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 71.6 m -93.4 158.83 15.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 73.150000000000006 110.876 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 63.240000000000002 110.928 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.789 0.328 . . . . 55.539999999999999 110.86 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -107.18 161.58 22.49 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.581 0.705 . . . . 75.349999999999994 110.933 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.74 -91.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.681 2.254 . . . . 72.409999999999997 112.31 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 6.5 p90 -155.15 -166.95 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 73.230000000000004 110.902 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.63 24.09 11.46 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.791 -0.718 . . . . 65.400000000000006 112.531 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -116.01 150.91 36.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.85 0.357 . . . . 75.099999999999994 110.953 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.65 138.2 36.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 73.450000000000003 110.862 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 p -144.31 161.88 37.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 74.140000000000001 110.923 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -154.99 -41.66 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 71.200000000000003 110.832 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.41 150.79 19.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 64.140000000000001 112.525 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.4 p -94.33 -31.45 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.767 0.317 . . . . 72.349999999999994 111.088 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.4 mp -63.88 -69.18 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 75.129999999999995 111.167 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -129.83 151.66 50.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 71.140000000000001 110.829 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.91 -76.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 72.129999999999995 110.927 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.2 m -123.01 149.23 44.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.443 . . . . 72.200000000000003 110.829 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.24 -168.38 2.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.489 . . . . 42.32 110.864 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.472 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -107.98 164.07 15.57 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.56 0.695 . . . . 73.540000000000006 110.893 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.472 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.76 -11.12 11.8 Favored 'Cis proline' 0 C--N 1.341 0.172 0 C-N-CA 122.676 -1.802 . . . . 72.420000000000002 112.363 0.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -41.69 152.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 74.519999999999996 110.899 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -151.35 129.19 11.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 75.209999999999994 110.901 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.45 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 36.3 m -70.62 114.61 8.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 75.010000000000005 110.868 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.406 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 68.0 m -119.25 118.98 32.23 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.562 0.696 . . . . 74.150000000000006 111.115 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.406 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.9 Cg_endo -69.73 168.66 66.57 Favored 'Cis proline' 0 C--N 1.341 0.177 0 C-N-CA 122.676 -1.802 . . . . 72.129999999999995 112.406 -0.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -7.57 21.38 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.699 2.266 . . . . 75.530000000000001 112.375 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.51 HD13 ' O ' ' A' ' 25' ' ' LEU . 0.9 OUTLIER -93.58 -44.74 8.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 51.409999999999997 111.006 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.404 HG23 ' O ' ' A' ' 26' ' ' ILE . 8.6 tt -174.6 123.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 61.219999999999999 111.127 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.42 -131.57 2.11 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.69 -0.767 . . . . 53.399999999999999 112.5 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 29' ' ' CYS . 12.2 mt -113.26 158.53 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 63.420000000000002 111.097 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.635 ' O ' HD22 ' A' ' 30' ' ' LEU . 80.8 m -90.81 130.82 36.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 73.150000000000006 110.888 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.635 HD22 ' O ' ' A' ' 29' ' ' CYS . 3.0 mm? . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 73.129999999999995 110.898 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.844 0.354 . . . . 72.209999999999994 110.883 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -95.52 150.42 37.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.579 0.704 . . . . 55.43 110.858 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.81 -166.22 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.677 2.251 . . . . 65.439999999999998 112.334 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -80.97 176.23 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 75.010000000000005 110.969 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.09 7.78 57.31 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.751 -0.738 . . . . 31.550000000000001 112.5 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.34 -172.93 2.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 74.319999999999993 110.906 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -114.37 135.12 54.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 74.540000000000006 110.881 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 1.034 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -136.79 171.07 15.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 75.5 110.841 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -160.29 -42.4 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 73.120000000000005 110.884 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.03 153.6 50.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.686 -0.769 . . . . 22.32 112.518 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.43 HG13 HG23 ' A' ' 12' ' ' ILE . 10.8 p -90.93 -34.44 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.884 0.373 . . . . 62.149999999999999 111.15 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.43 HG23 HG13 ' A' ' 11' ' ' VAL . 1.3 pp -87.95 -25.41 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 74.25 111.084 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -128.27 113.18 15.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 71.129999999999995 110.879 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -174.25 -168.22 0.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 61.210000000000001 110.905 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 74.6 m -48.02 147.31 2.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 73.150000000000006 110.889 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.77 -167.62 1.73 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 71.319999999999993 110.873 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -100.41 163.44 18.21 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.654 0.74 . . . . 75.420000000000002 110.859 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.75 -12.17 12.1 Favored 'Cis proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.715 -1.785 . . . . 61.420000000000002 112.364 -0.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -44.65 155.34 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 64.510000000000005 110.988 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -146.24 127.87 15.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 74.129999999999995 110.82 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.536 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 55.5 m -60.53 122.67 15.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 63.229999999999997 110.888 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 22' ' ' THR . 5.9 t -121.51 116.22 30.76 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.578 0.704 . . . . 64.329999999999998 111.129 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 168.23 68.47 Favored 'Cis proline' 0 C--N 1.342 0.213 0 C-N-CA 122.644 -1.815 . . . . 62.420000000000002 112.382 -0.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 63.28 1.76 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.679 2.253 . . . . 75.420000000000002 112.356 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.451 HD12 HG22 ' A' ' 26' ' ' ILE . 2.6 tm? -174.69 -67.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.424 . . . . 73.140000000000001 110.927 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.451 HG22 HD12 ' A' ' 25' ' ' LEU . 17.7 tt -149.75 141.92 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 74.219999999999999 111.139 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.419 ' C ' HD13 ' A' ' 28' ' ' ILE . . . 136.9 -112.89 0.98 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.723 -0.751 . . . . 74.450000000000003 112.548 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.498 HG22 ' H ' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -110.33 -172.91 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 70.430000000000007 111.146 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 1.034 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 41.3 m -136.58 150.51 48.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 64.099999999999994 110.887 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 74.530000000000001 110.884 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.822 0.344 . . . . 45.409999999999997 110.869 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -109.77 157.71 36.86 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.696 0.76 . . . . 62.43 110.81 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -166.87 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.659 2.239 . . . . 75.329999999999998 112.36 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -85.45 179.25 7.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 64.040000000000006 110.944 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.94 12.33 54.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.689 -0.767 . . . . 43.420000000000002 112.449 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.84 168.73 8.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.93 0.395 . . . . 74.519999999999996 110.893 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.05 146.96 23.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.07 -0.514 . . . . 64.319999999999993 110.766 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.828 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -150.16 156.45 41.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 51.520000000000003 110.878 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -141.6 -42.16 0.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 74.049999999999997 110.9 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.05 -179.6 0.41 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.688 -0.768 . . . . 51.149999999999999 112.493 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.8 p -128.29 -39.42 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 63.229999999999997 111.125 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.464 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -73.84 -25.77 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 73.540000000000006 111.119 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.01 132.22 8.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 74.120000000000005 110.92 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -165.07 -76.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 74.140000000000001 110.949 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 m -120.87 134.33 55.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 63.229999999999997 110.893 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.99 -167.54 0.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 44.340000000000003 110.83 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.484 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -111.85 162.85 19.36 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.604 0.716 . . . . 51.420000000000002 110.858 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.73 -9.16 10.81 Favored 'Cis proline' 0 C--N 1.343 0.238 0 C-N-CA 122.674 -1.803 . . . . 73.129999999999995 112.327 -0.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -40.33 151.42 0.05 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.26 -0.427 . . . . 72.5 110.926 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -150.37 132.6 15.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 71.510000000000005 110.811 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.579 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 65.7 m -69.18 121.39 16.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 52.350000000000001 110.867 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.412 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 54.7 m -123.93 118.25 27.0 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.633 0.73 . . . . 72.530000000000001 111.091 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.412 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.83 164.05 80.44 Favored 'Cis proline' 0 C--N 1.342 0.202 0 C-N-CA 122.686 -1.797 . . . . 61.509999999999998 112.342 -0.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 63.09 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.648 2.232 . . . . 73.420000000000002 112.364 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.591 HD13 HG13 ' A' ' 26' ' ' ILE . 2.0 tm? -174.97 -68.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 61.530000000000001 110.95 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.591 HG13 HD13 ' A' ' 25' ' ' LEU . 27.8 mt -142.84 114.39 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 75.439999999999998 111.114 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.27 -128.84 1.82 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.71 -0.757 . . . . 72.319999999999993 112.447 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.4 HG22 ' H ' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -106.5 -170.83 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.893 0.377 . . . . 74.439999999999998 111.134 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.828 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 58.1 m -130.47 149.63 52.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.472 . . . . 65.439999999999998 110.879 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.467 . . . . 64.340000000000003 110.851 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.841 0.353 . . . . 72.310000000000002 110.911 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -105.67 159.32 29.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.644 0.735 . . . . 74.420000000000002 110.848 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -90.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.707 2.272 . . . . 53.229999999999997 112.316 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.42 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 17.0 p90 -153.7 -164.5 1.9 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 75.140000000000001 110.998 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.34 27.13 15.55 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.697 -0.763 . . . . 74.409999999999997 112.481 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -125.34 155.09 40.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.892 0.377 . . . . 72.129999999999995 110.959 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -79.71 124.22 28.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 63.439999999999998 110.923 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.765 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.8 p -131.24 146.51 52.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 65.540000000000006 110.832 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -134.02 -44.54 0.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.103 -0.499 . . . . 74.209999999999994 110.878 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.53 149.83 7.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.796 -0.716 . . . . 74.109999999999999 112.501 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.13 -20.98 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 61.43 111.102 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 13' ' ' ASN . 5.5 tt -115.86 -44.57 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 70.230000000000004 111.117 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.425 ' N ' HG23 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -92.14 99.08 11.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 73.120000000000005 110.914 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -169.06 -167.06 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 72.019999999999996 110.912 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 80.5 m -49.77 133.18 21.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 72.409999999999997 110.823 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -79.03 -169.05 1.66 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 75.439999999999998 110.847 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.498 ' CB ' ' HA ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -94.4 165.94 16.42 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.583 0.706 . . . . 73.219999999999999 110.838 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.498 ' HA ' ' CB ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.73 -14.08 12.39 Favored 'Cis proline' 0 C--N 1.341 0.133 0 C-N-CA 122.682 -1.799 . . . . 60.210000000000001 112.4 -0.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -44.14 156.95 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 72.219999999999999 110.946 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -148.67 130.22 14.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 73.219999999999999 110.784 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.568 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 57.9 m -71.89 113.05 8.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.467 . . . . 54.009999999999998 110.902 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.411 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 66.9 m -119.38 118.33 32.5 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.551 0.691 . . . . 64.340000000000003 111.151 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.462 ' HD2' ' HA3' ' A' ' 27' ' ' GLY . 53.6 Cg_endo -69.76 170.44 58.48 Favored 'Cis proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.699 -1.792 . . . . 75.310000000000002 112.337 -0.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 -5.95 17.41 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.727 2.285 . . . . 70.010000000000005 112.381 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.6 -66.26 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 53.32 110.905 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.5 mt -151.72 128.1 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 60.520000000000003 111.119 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.462 ' HA3' ' HD2' ' A' ' 23' ' ' PRO . . . 166.32 -132.03 2.53 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.691 -0.766 . . . . 74.519999999999996 112.449 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.485 HG22 ' H ' ' A' ' 29' ' ' CYS . 3.0 mm -110.35 167.32 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.872 0.368 . . . . 74.049999999999997 111.16 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.765 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 86.7 m -104.98 134.63 47.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 50.25 110.848 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.625 HD22 ' O ' ' A' ' 29' ' ' CYS . 2.5 mm? . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 63.109999999999999 110.893 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.861 0.363 . . . . 63.140000000000001 110.829 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.5 ptt-85 -104.73 155.09 37.99 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.578 0.704 . . . . 75.040000000000006 110.913 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -168.14 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.754 2.302 . . . . 61.240000000000002 112.31 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -80.83 -170.6 2.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 63.43 110.955 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.79 30.31 14.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 71.510000000000005 112.526 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.35 160.22 24.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.348 . . . . 62.530000000000001 110.926 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -88.56 127.31 35.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 64.109999999999999 110.855 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.593 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.4 p -137.54 161.91 35.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 55.409999999999997 110.912 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -156.42 -41.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 45.549999999999997 110.849 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.03 153.63 4.28 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 50.229999999999997 112.494 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.3 p -101.18 -35.65 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.814 0.34 . . . . 70.5 111.136 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.613 HD12 ' HB2' ' A' ' 13' ' ' ASN . 2.4 pp -77.69 -34.84 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 62.219999999999999 111.128 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.613 ' HB2' HD12 ' A' ' 12' ' ' ILE . 11.4 t30 -132.51 137.47 47.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 72.040000000000006 110.906 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -174.86 -169.01 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 70.5 110.916 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 66.0 m -49.78 147.69 3.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 64.200000000000003 110.84 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.97 -166.46 1.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 65.209999999999994 110.937 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.465 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -103.09 164.53 15.32 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.605 0.717 . . . . 61.310000000000002 110.849 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.465 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.0 Cg_endo -69.85 -12.89 12.5 Favored 'Cis proline' 0 C--O 1.232 0.194 0 C-N-CA 122.675 -1.802 . . . . 75.319999999999993 112.294 0.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -43.69 154.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 53.420000000000002 110.908 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -150.1 130.53 13.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 72.129999999999995 110.797 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 97.9 m -70.83 114.22 8.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 54.329999999999998 110.856 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.9 m -120.81 117.23 31.19 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 121.614 0.721 . . . . 55.119999999999997 111.158 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 168.83 65.96 Favored 'Cis proline' 0 C--N 1.341 0.143 0 C-N-CA 122.717 -1.785 . . . . 63.539999999999999 112.304 -0.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -7.58 21.4 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.706 2.271 . . . . 65.049999999999997 112.351 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -92.64 -45.51 8.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 71.420000000000002 110.883 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.2 tt -177.46 127.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 72.420000000000002 111.137 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.8 -124.81 1.18 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.783 -0.722 . . . . 43.539999999999999 112.517 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.0 mm -116.62 155.53 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.897 0.379 . . . . 55.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.617 ' O ' HD22 ' A' ' 30' ' ' LEU . 64.3 m -91.84 132.03 36.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 71.329999999999998 110.871 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.617 HD22 ' O ' ' A' ' 29' ' ' CYS . 3.4 mm? . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 51.310000000000002 110.903 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.839 0.352 . . . . 71.400000000000006 110.852 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -104.12 152.7 39.19 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.596 0.712 . . . . 73.109999999999999 110.864 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -168.57 0.28 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.681 2.254 . . . . 55.009999999999998 112.349 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -78.56 -170.18 1.99 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 72.040000000000006 110.954 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.85 29.43 13.48 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.792 -0.718 . . . . 52.219999999999999 112.467 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.12 157.83 29.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.868 0.366 . . . . 75.319999999999993 110.921 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.42 126.82 33.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.063 -0.517 . . . . 74.299999999999997 110.856 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 2.3 p -144.83 162.43 36.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 63.140000000000001 110.901 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.483 ' HB3' HD13 ' A' ' 26' ' ' ILE . 4.8 p-10 -160.37 -41.62 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 73.239999999999995 110.881 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.48 162.56 1.46 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.742 -0.742 . . . . 60.5 112.529 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.19 -37.62 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.763 0.316 . . . . 73.319999999999993 111.111 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.8 pp -68.99 -24.43 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 71.409999999999997 111.127 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -151.29 137.59 18.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 71.150000000000006 110.881 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -174.1 -168.7 0.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.118 -0.492 . . . . 64.329999999999998 110.885 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 95.6 m -50.67 146.19 5.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 73.340000000000003 110.864 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -85.92 -168.07 2.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 70.25 110.909 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.468 ' CB ' ' HA ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -100.03 164.6 16.12 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.643 0.735 . . . . 71.430000000000007 110.874 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.468 ' HA ' ' CB ' ' A' ' 17' ' ' ASP . 54.2 Cg_endo -69.81 -13.21 12.46 Favored 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.672 -1.803 . . . . 63.310000000000002 112.385 0.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -45.29 155.02 0.14 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 75.519999999999996 110.938 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -150.33 129.35 12.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.068 -0.514 . . . . 72.430000000000007 110.824 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 87.9 m -69.5 109.08 4.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 74.150000000000006 110.843 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.48 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 99.5 m -123.69 125.43 25.97 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.582 0.706 . . . . 70.129999999999995 111.174 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.1 Cg_endo -69.78 155.58 93.23 Favored 'Cis proline' 0 C--N 1.342 0.223 0 C-N-CA 122.655 -1.81 . . . . 64.530000000000001 112.361 -0.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 67.97 1.73 Allowed 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.726 2.284 . . . . 75.420000000000002 112.302 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.8 -34.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 74.230000000000004 110.882 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.483 HD13 ' HB3' ' A' ' 9' ' ' ASP . 4.5 tp 179.87 115.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.235 -0.439 . . . . 71.120000000000005 111.159 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.449 ' O ' HD13 ' A' ' 28' ' ' ILE . . . 167.03 -125.84 1.37 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.713 -0.756 . . . . 63.140000000000001 112.435 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 27' ' ' GLY . 11.9 mm -121.1 159.03 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.872 0.367 . . . . 74.200000000000003 111.151 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 75.0 m -95.63 136.45 36.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 65.349999999999994 110.886 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.595 HD22 ' O ' ' A' ' 29' ' ' CYS . 3.5 mm? . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 74.0 110.928 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.86 0.362 . . . . 54.32 110.786 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -106.46 158.09 33.48 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.633 0.73 . . . . 74.150000000000006 110.819 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 -168.87 0.29 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.695 2.263 . . . . 72.109999999999999 112.377 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.405 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 16.4 p90 -80.37 -169.33 2.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 71.310000000000002 110.892 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.6 27.38 18.52 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.747 -0.74 . . . . 72.329999999999998 112.486 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -119.29 154.01 34.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.862 0.363 . . . . 73.340000000000003 110.91 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.79 142.27 28.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.491 . . . . 70.420000000000002 110.807 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.62 161.83 38.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 54.200000000000003 110.949 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -150.8 -41.46 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 74.5 110.892 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.4 170.5 0.32 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.812 -0.709 . . . . 44.350000000000001 112.453 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 p -112.31 -39.56 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 72.409999999999997 111.145 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.443 HD12 ' H ' ' A' ' 12' ' ' ILE . 3.9 mp -61.95 -70.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 72.140000000000001 111.175 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -126.21 147.26 49.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 55.32 110.93 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -162.94 -76.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 74.349999999999994 110.844 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.1 m -121.76 143.15 49.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 73.420000000000002 110.92 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.69 -169.93 1.92 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 74.129999999999995 110.925 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.469 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -106.89 164.69 14.3 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.563 0.697 . . . . 71.219999999999999 110.914 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.469 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.87 -11.66 12.17 Favored 'Cis proline' 0 C--O 1.232 0.175 0 C-N-CA 122.634 -1.819 . . . . 73.530000000000001 112.353 0.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -42.38 151.95 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 75.400000000000006 110.876 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -150.53 132.72 15.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.021 -0.536 . . . . 75.329999999999998 110.865 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.1 m -69.54 112.96 6.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 71.120000000000005 110.891 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.4 m -121.56 117.05 30.33 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.603 0.716 . . . . 74.519999999999996 111.129 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 169.34 63.86 Favored 'Cis proline' 0 C--N 1.342 0.205 0 C-N-CA 122.627 -1.822 . . . . 73.329999999999998 112.363 -0.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.75 -7.21 20.48 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.692 2.261 . . . . 53.450000000000003 112.325 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -94.01 -53.22 4.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.268 -0.424 . . . . 62.149999999999999 110.93 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.6 tt -165.33 125.07 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 74.0 111.183 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.41 -124.97 1.12 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.817 -0.706 . . . . 73.230000000000004 112.527 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.15 170.19 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.88 0.372 . . . . 62.409999999999997 111.109 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.641 ' O ' HD22 ' A' ' 30' ' ' LEU . 66.4 m -100.13 130.38 46.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 65.140000000000001 110.955 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.641 HD22 ' O ' ' A' ' 29' ' ' CYS . 3.9 mm? . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 75.340000000000003 110.938 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.813 0.339 . . . . 72.200000000000003 110.933 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -105.24 153.34 39.67 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.597 0.713 . . . . 74.25 110.847 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -169.08 0.31 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.688 2.259 . . . . 73.439999999999998 112.311 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -78.83 -170.64 2.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 73.439999999999998 110.9 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 50.23 28.55 13.86 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.708 -0.758 . . . . 53.240000000000002 112.497 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.58 155.26 34.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.855 0.359 . . . . 75.540000000000006 110.888 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -83.6 124.39 30.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 74.329999999999998 110.904 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.8 p -135.12 153.82 51.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 71.099999999999994 110.937 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -167.25 125.48 1.29 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 72.400000000000006 110.887 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.2 -133.18 6.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.655 -0.784 . . . . 71.530000000000001 112.486 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.6 p -169.53 -37.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.809 0.338 . . . . 64.239999999999995 111.171 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.42 HG23 ' N ' ' A' ' 13' ' ' ASN . 5.1 tt -51.93 -44.97 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 72.329999999999998 111.127 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.42 ' N ' HG23 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -153.56 152.95 31.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 60.25 110.825 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -174.34 -167.09 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 74.439999999999998 110.965 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 96.8 m -49.62 146.45 4.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.303 -0.408 . . . . 74.510000000000005 110.853 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.25 -167.9 2.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.310000000000002 110.87 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.469 ' CB ' ' HA ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -99.68 164.7 16.06 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.573 0.701 . . . . 53.43 110.823 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.469 ' HA ' ' CB ' ' A' ' 17' ' ' ASP . 54.0 Cg_endo -69.65 -13.31 12.16 Favored 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.712 -1.787 . . . . 75.230000000000004 112.391 -0.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -45.46 155.22 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 74.420000000000002 110.898 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -150.21 129.66 12.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 64.439999999999998 110.909 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 67.2 m -70.03 111.38 5.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 73.349999999999994 110.945 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.467 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 80.4 m -122.62 124.11 26.8 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.604 0.716 . . . . 52.420000000000002 111.121 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.6 Cg_endo -69.72 157.63 91.76 Favored 'Cis proline' 0 C--N 1.342 0.189 0 C-N-CA 122.701 -1.791 . . . . 65.019999999999996 112.368 -0.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 64.04 1.79 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.722 2.282 . . . . 65.329999999999998 112.337 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -175.83 -36.09 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 64.140000000000001 110.882 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 26' ' ' ILE . 1.3 tt -178.43 116.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.266 -0.425 . . . . 74.239999999999995 111.144 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.61 -126.68 1.46 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.795 -0.717 . . . . 41.240000000000002 112.545 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 29' ' ' CYS . 10.8 mm -117.62 159.32 17.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.875 0.369 . . . . 55.439999999999998 111.122 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 78.1 m -96.38 134.03 40.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 61.43 110.912 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.594 HD22 ' O ' ' A' ' 29' ' ' CYS . 3.3 mm? . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 73.319999999999993 110.931 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.811 0.339 . . . . 74.510000000000005 110.95 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.78 157.58 33.62 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.59 0.71 . . . . 62.530000000000001 110.868 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -168.58 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.692 2.261 . . . . 74.200000000000003 112.31 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -80.0 -170.82 2.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 71.219999999999999 110.932 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 50.87 27.9 14.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.781 -0.723 . . . . 75.400000000000006 112.466 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -120.24 153.08 36.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.836 0.351 . . . . 75.120000000000005 110.907 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.77 137.99 35.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.505 . . . . 71.040000000000006 110.897 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.1 p -150.75 155.88 40.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 72.25 110.867 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.73 117.78 4.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 71.129999999999995 110.859 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.05 -130.61 5.38 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.695 -0.764 . . . . 30.120000000000001 112.474 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -176.81 -35.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 75.510000000000005 111.082 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.466 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -57.69 -26.59 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 70.510000000000005 111.094 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -179.74 133.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 74.519999999999996 110.866 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.49 -77.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 65.450000000000003 110.922 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.3 m -120.85 149.15 43.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 53.350000000000001 110.873 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.23 -169.29 2.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 74.109999999999999 110.809 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.468 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -106.7 164.54 14.65 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.611 0.719 . . . . 45.310000000000002 110.858 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.468 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.66 -11.92 11.85 Favored 'Cis proline' 0 C--N 1.342 0.21 0 C-N-CA 122.71 -1.787 . . . . 73.129999999999995 112.356 -0.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -42.26 152.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 65.129999999999995 110.898 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -150.72 130.51 13.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 72.120000000000005 110.863 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 60.2 m -70.54 114.69 8.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 74.420000000000002 110.819 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.463 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 98.4 m -123.84 123.36 26.24 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.539 0.685 . . . . 74.019999999999996 111.182 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.463 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.81 158.07 91.55 Favored 'Cis proline' 0 C--N 1.341 0.163 0 C-N-CA 122.627 -1.822 . . . . 72.409999999999997 112.358 0.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 64.44 1.79 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.706 2.27 . . . . 74.239999999999995 112.297 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -177.2 -34.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 74.420000000000002 110.861 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.455 ' O ' HG23 ' A' ' 26' ' ' ILE . 4.7 tt -176.88 107.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 72.420000000000002 111.16 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 176.46 -132.31 2.05 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.661 -0.78 . . . . 74.420000000000002 112.442 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 29' ' ' CYS . 12.1 mm -116.06 158.87 16.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.869 0.366 . . . . 51.210000000000001 111.162 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.625 ' O ' HD22 ' A' ' 30' ' ' LEU . 79.3 m -90.6 132.46 35.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 54.140000000000001 110.898 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.625 HD22 ' O ' ' A' ' 29' ' ' CYS . 3.7 mm? . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 65.030000000000001 110.885 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.785 0.326 . . . . 73.120000000000005 110.907 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -110.46 157.96 36.74 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.598 0.713 . . . . 73.310000000000002 110.907 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -167.14 0.21 Allowed 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.734 2.289 . . . . 65.439999999999998 112.351 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -82.03 178.23 8.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 52.340000000000003 110.945 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.33 13.25 53.83 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.689 -0.767 . . . . 74.019999999999996 112.514 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -101.82 172.76 6.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.875 0.369 . . . . 74.209999999999994 110.942 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.22 125.86 43.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 70.040000000000006 110.954 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.96 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.2 p -132.94 168.62 18.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 61.299999999999997 110.901 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -157.2 -42.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 73.040000000000006 110.812 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.81 173.1 0.88 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.827 -0.702 . . . . 65.420000000000002 112.459 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.6 m -121.29 -7.64 9.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.874 0.369 . . . . 64.019999999999996 111.11 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.2 pp -115.73 -24.29 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 52.310000000000002 111.147 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.45 120.4 7.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 72.219999999999999 110.86 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -163.07 -78.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 63.420000000000002 110.883 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.8 m -122.45 134.11 54.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 73.420000000000002 110.858 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.07 -177.08 2.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 75.109999999999999 110.892 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.481 ' CB ' ' HA ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -101.38 165.05 14.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.655 0.741 . . . . 73.239999999999995 110.823 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.481 ' HA ' ' CB ' ' A' ' 17' ' ' ASP . 53.9 Cg_endo -69.75 -12.09 12.06 Favored 'Cis proline' 0 C--N 1.342 0.217 0 C-N-CA 122.693 -1.794 . . . . 74.329999999999998 112.362 0.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -47.73 159.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 72.340000000000003 110.931 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -143.95 -169.98 3.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.507 . . . . 74.340000000000003 110.899 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.521 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 44.9 m -125.1 119.09 27.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 64.109999999999999 110.84 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.465 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 88.5 m -129.19 124.17 22.07 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.564 0.697 . . . . 70.109999999999999 111.14 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.465 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.74 159.53 89.47 Favored 'Cis proline' 0 C--O 1.232 0.193 0 C-N-CA 122.68 -1.8 . . . . 71.120000000000005 112.341 -0.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 63.74 1.82 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.678 2.252 . . . . 74.030000000000001 112.338 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.598 HD13 ' O ' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -175.48 -39.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 70.219999999999999 110.916 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.4 tt -177.97 127.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 73.530000000000001 111.075 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.03 -124.65 1.55 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.732 -0.747 . . . . 61.219999999999999 112.438 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.2 mm -114.81 152.39 16.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 73.120000000000005 111.205 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.96 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 71.6 m -93.4 158.83 15.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 73.150000000000006 110.876 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 63.240000000000002 110.928 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.789 0.328 . . . . 55.539999999999999 110.86 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -107.18 161.58 22.49 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.581 0.705 . . . . 75.349999999999994 110.933 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.74 -91.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.681 2.254 . . . . 72.409999999999997 112.31 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 6.5 p90 -155.15 -166.95 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 73.230000000000004 110.902 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.63 24.09 11.46 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.791 -0.718 . . . . 65.400000000000006 112.531 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -116.01 150.91 36.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.85 0.357 . . . . 75.099999999999994 110.953 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.65 138.2 36.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 73.450000000000003 110.862 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 p -144.31 161.88 37.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 74.140000000000001 110.923 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -154.99 -41.66 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 71.200000000000003 110.832 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.41 150.79 19.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 64.140000000000001 112.525 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.4 p -94.33 -31.45 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.767 0.317 . . . . 72.349999999999994 111.088 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.4 mp -63.88 -69.18 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 75.129999999999995 111.167 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -129.83 151.66 50.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 71.140000000000001 110.829 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.91 -76.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 72.129999999999995 110.927 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.2 m -123.01 149.23 44.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.443 . . . . 72.200000000000003 110.829 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.24 -168.38 2.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.489 . . . . 42.32 110.864 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.472 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -107.98 164.07 15.57 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.56 0.695 . . . . 73.540000000000006 110.893 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.472 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.76 -11.12 11.8 Favored 'Cis proline' 0 C--N 1.341 0.172 0 C-N-CA 122.676 -1.802 . . . . 72.420000000000002 112.363 0.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -41.69 152.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 74.519999999999996 110.899 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -151.35 129.19 11.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 75.209999999999994 110.901 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.45 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 36.3 m -70.62 114.61 8.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 75.010000000000005 110.868 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.406 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 68.0 m -119.25 118.98 32.23 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.562 0.696 . . . . 74.150000000000006 111.115 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.406 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.9 Cg_endo -69.73 168.66 66.57 Favored 'Cis proline' 0 C--N 1.341 0.177 0 C-N-CA 122.676 -1.802 . . . . 72.129999999999995 112.406 -0.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -7.57 21.38 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.699 2.266 . . . . 75.530000000000001 112.375 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.51 HD13 ' O ' ' A' ' 25' ' ' LEU . 0.9 OUTLIER -93.58 -44.74 8.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 51.409999999999997 111.006 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.404 HG23 ' O ' ' A' ' 26' ' ' ILE . 8.6 tt -174.6 123.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 61.219999999999999 111.127 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.42 -131.57 2.11 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.69 -0.767 . . . . 53.399999999999999 112.5 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 29' ' ' CYS . 12.2 mt -113.26 158.53 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 63.420000000000002 111.097 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.635 ' O ' HD22 ' A' ' 30' ' ' LEU . 80.8 m -90.81 130.82 36.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 73.150000000000006 110.888 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.635 HD22 ' O ' ' A' ' 29' ' ' CYS . 3.0 mm? . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 73.129999999999995 110.898 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.844 0.354 . . . . 72.209999999999994 110.883 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -95.52 150.42 37.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.579 0.704 . . . . 55.43 110.858 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.81 -166.22 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.677 2.251 . . . . 65.439999999999998 112.334 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -80.97 176.23 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 75.010000000000005 110.969 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.09 7.78 57.31 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.751 -0.738 . . . . 31.550000000000001 112.5 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.34 -172.93 2.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 74.319999999999993 110.906 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -114.37 135.12 54.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 74.540000000000006 110.881 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 1.034 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -136.79 171.07 15.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 75.5 110.841 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -160.29 -42.4 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 73.120000000000005 110.884 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.03 153.6 50.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.686 -0.769 . . . . 22.32 112.518 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.43 HG13 HG23 ' A' ' 12' ' ' ILE . 10.8 p -90.93 -34.44 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.884 0.373 . . . . 62.149999999999999 111.15 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.43 HG23 HG13 ' A' ' 11' ' ' VAL . 1.3 pp -87.95 -25.41 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 74.25 111.084 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -128.27 113.18 15.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 71.129999999999995 110.879 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -174.25 -168.22 0.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 61.210000000000001 110.905 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 74.6 m -48.02 147.31 2.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 73.150000000000006 110.889 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.77 -167.62 1.73 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 71.319999999999993 110.873 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -100.41 163.44 18.21 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.654 0.74 . . . . 75.420000000000002 110.859 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.75 -12.17 12.1 Favored 'Cis proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.715 -1.785 . . . . 61.420000000000002 112.364 -0.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -44.65 155.34 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 64.510000000000005 110.988 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -146.24 127.87 15.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 74.129999999999995 110.82 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.536 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 55.5 m -60.53 122.67 15.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 63.229999999999997 110.888 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 22' ' ' THR . 5.9 t -121.51 116.22 30.76 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.578 0.704 . . . . 64.329999999999998 111.129 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 168.23 68.47 Favored 'Cis proline' 0 C--N 1.342 0.213 0 C-N-CA 122.644 -1.815 . . . . 62.420000000000002 112.382 -0.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 63.28 1.76 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.679 2.253 . . . . 75.420000000000002 112.356 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.451 HD12 HG22 ' A' ' 26' ' ' ILE . 2.6 tm? -174.69 -67.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.424 . . . . 73.140000000000001 110.927 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.451 HG22 HD12 ' A' ' 25' ' ' LEU . 17.7 tt -149.75 141.92 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 74.219999999999999 111.139 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.419 ' C ' HD13 ' A' ' 28' ' ' ILE . . . 136.9 -112.89 0.98 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.723 -0.751 . . . . 74.450000000000003 112.548 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.498 HG22 ' H ' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -110.33 -172.91 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 70.430000000000007 111.146 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 1.034 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 41.3 m -136.58 150.51 48.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 64.099999999999994 110.887 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 74.530000000000001 110.884 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.822 0.344 . . . . 45.409999999999997 110.869 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -109.77 157.71 36.86 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.696 0.76 . . . . 62.43 110.81 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -166.87 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.659 2.239 . . . . 75.329999999999998 112.36 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -85.45 179.25 7.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 64.040000000000006 110.944 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.94 12.33 54.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.689 -0.767 . . . . 43.420000000000002 112.449 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.84 168.73 8.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.93 0.395 . . . . 74.519999999999996 110.893 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.05 146.96 23.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.07 -0.514 . . . . 64.319999999999993 110.766 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.828 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -150.16 156.45 41.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 51.520000000000003 110.878 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -141.6 -42.16 0.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 74.049999999999997 110.9 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.05 -179.6 0.41 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.688 -0.768 . . . . 51.149999999999999 112.493 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.8 p -128.29 -39.42 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 63.229999999999997 111.125 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.464 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -73.84 -25.77 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 73.540000000000006 111.119 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.01 132.22 8.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 74.120000000000005 110.92 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -165.07 -76.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 74.140000000000001 110.949 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 m -120.87 134.33 55.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 63.229999999999997 110.893 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.99 -167.54 0.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 44.340000000000003 110.83 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.484 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -111.85 162.85 19.36 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.604 0.716 . . . . 51.420000000000002 110.858 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.73 -9.16 10.81 Favored 'Cis proline' 0 C--N 1.343 0.238 0 C-N-CA 122.674 -1.803 . . . . 73.129999999999995 112.327 -0.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -40.33 151.42 0.05 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.26 -0.427 . . . . 72.5 110.926 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -150.37 132.6 15.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 71.510000000000005 110.811 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.579 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 65.7 m -69.18 121.39 16.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 52.350000000000001 110.867 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.412 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 54.7 m -123.93 118.25 27.0 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.633 0.73 . . . . 72.530000000000001 111.091 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.412 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.83 164.05 80.44 Favored 'Cis proline' 0 C--N 1.342 0.202 0 C-N-CA 122.686 -1.797 . . . . 61.509999999999998 112.342 -0.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 63.09 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.648 2.232 . . . . 73.420000000000002 112.364 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.591 HD13 HG13 ' A' ' 26' ' ' ILE . 2.0 tm? -174.97 -68.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 61.530000000000001 110.95 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.591 HG13 HD13 ' A' ' 25' ' ' LEU . 27.8 mt -142.84 114.39 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 75.439999999999998 111.114 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.27 -128.84 1.82 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.71 -0.757 . . . . 72.319999999999993 112.447 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.4 HG22 ' H ' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -106.5 -170.83 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.893 0.377 . . . . 74.439999999999998 111.134 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.828 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 58.1 m -130.47 149.63 52.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.472 . . . . 65.439999999999998 110.879 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.467 . . . . 64.340000000000003 110.851 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.841 0.353 . . . . 72.310000000000002 110.911 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -105.67 159.32 29.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.644 0.735 . . . . 74.420000000000002 110.848 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -90.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.707 2.272 . . . . 53.229999999999997 112.316 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.42 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 17.0 p90 -153.7 -164.5 1.9 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 75.140000000000001 110.998 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.34 27.13 15.55 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.697 -0.763 . . . . 74.409999999999997 112.481 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -125.34 155.09 40.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.892 0.377 . . . . 72.129999999999995 110.959 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -79.71 124.22 28.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 63.439999999999998 110.923 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.765 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.8 p -131.24 146.51 52.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 65.540000000000006 110.832 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -134.02 -44.54 0.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.103 -0.499 . . . . 74.209999999999994 110.878 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.53 149.83 7.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.796 -0.716 . . . . 74.109999999999999 112.501 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.13 -20.98 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 61.43 111.102 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 13' ' ' ASN . 5.5 tt -115.86 -44.57 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 70.230000000000004 111.117 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.425 ' N ' HG23 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -92.14 99.08 11.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 73.120000000000005 110.914 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -169.06 -167.06 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 72.019999999999996 110.912 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 80.5 m -49.77 133.18 21.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 72.409999999999997 110.823 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -79.03 -169.05 1.66 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 75.439999999999998 110.847 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.498 ' CB ' ' HA ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -94.4 165.94 16.42 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.583 0.706 . . . . 73.219999999999999 110.838 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.498 ' HA ' ' CB ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.73 -14.08 12.39 Favored 'Cis proline' 0 C--N 1.341 0.133 0 C-N-CA 122.682 -1.799 . . . . 60.210000000000001 112.4 -0.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -44.14 156.95 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 72.219999999999999 110.946 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -148.67 130.22 14.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 73.219999999999999 110.784 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.568 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 57.9 m -71.89 113.05 8.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.467 . . . . 54.009999999999998 110.902 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.411 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 66.9 m -119.38 118.33 32.5 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.551 0.691 . . . . 64.340000000000003 111.151 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.462 ' HD2' ' HA3' ' A' ' 27' ' ' GLY . 53.6 Cg_endo -69.76 170.44 58.48 Favored 'Cis proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.699 -1.792 . . . . 75.310000000000002 112.337 -0.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 -5.95 17.41 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.727 2.285 . . . . 70.010000000000005 112.381 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.6 -66.26 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 53.32 110.905 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.5 mt -151.72 128.1 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 60.520000000000003 111.119 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.462 ' HA3' ' HD2' ' A' ' 23' ' ' PRO . . . 166.32 -132.03 2.53 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.691 -0.766 . . . . 74.519999999999996 112.449 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.485 HG22 ' H ' ' A' ' 29' ' ' CYS . 3.0 mm -110.35 167.32 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.872 0.368 . . . . 74.049999999999997 111.16 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.765 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 86.7 m -104.98 134.63 47.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 50.25 110.848 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.625 HD22 ' O ' ' A' ' 29' ' ' CYS . 2.5 mm? . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 63.109999999999999 110.893 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.861 0.363 . . . . 63.140000000000001 110.829 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.5 ptt-85 -104.73 155.09 37.99 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.578 0.704 . . . . 75.040000000000006 110.913 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -168.14 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.754 2.302 . . . . 61.240000000000002 112.31 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -80.83 -170.6 2.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 63.43 110.955 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.79 30.31 14.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 71.510000000000005 112.526 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.35 160.22 24.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.348 . . . . 62.530000000000001 110.926 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -88.56 127.31 35.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 64.109999999999999 110.855 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.593 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.4 p -137.54 161.91 35.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 55.409999999999997 110.912 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -156.42 -41.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 45.549999999999997 110.849 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.03 153.63 4.28 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 50.229999999999997 112.494 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.3 p -101.18 -35.65 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.814 0.34 . . . . 70.5 111.136 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.613 HD12 ' HB2' ' A' ' 13' ' ' ASN . 2.4 pp -77.69 -34.84 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 62.219999999999999 111.128 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.613 ' HB2' HD12 ' A' ' 12' ' ' ILE . 11.4 t30 -132.51 137.47 47.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 72.040000000000006 110.906 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -174.86 -169.01 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 70.5 110.916 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 66.0 m -49.78 147.69 3.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 64.200000000000003 110.84 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.97 -166.46 1.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 65.209999999999994 110.937 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.465 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -103.09 164.53 15.32 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.605 0.717 . . . . 61.310000000000002 110.849 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.465 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.0 Cg_endo -69.85 -12.89 12.5 Favored 'Cis proline' 0 C--O 1.232 0.194 0 C-N-CA 122.675 -1.802 . . . . 75.319999999999993 112.294 0.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -43.69 154.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 53.420000000000002 110.908 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -150.1 130.53 13.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 72.129999999999995 110.797 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 97.9 m -70.83 114.22 8.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 54.329999999999998 110.856 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.9 m -120.81 117.23 31.19 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 121.614 0.721 . . . . 55.119999999999997 111.158 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 168.83 65.96 Favored 'Cis proline' 0 C--N 1.341 0.143 0 C-N-CA 122.717 -1.785 . . . . 63.539999999999999 112.304 -0.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -7.58 21.4 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.706 2.271 . . . . 65.049999999999997 112.351 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -92.64 -45.51 8.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 71.420000000000002 110.883 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.2 tt -177.46 127.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 72.420000000000002 111.137 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.8 -124.81 1.18 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.783 -0.722 . . . . 43.539999999999999 112.517 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.0 mm -116.62 155.53 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.897 0.379 . . . . 55.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.617 ' O ' HD22 ' A' ' 30' ' ' LEU . 64.3 m -91.84 132.03 36.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 71.329999999999998 110.871 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.617 HD22 ' O ' ' A' ' 29' ' ' CYS . 3.4 mm? . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 51.310000000000002 110.903 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.839 0.352 . . . . 71.400000000000006 110.852 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -104.12 152.7 39.19 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.596 0.712 . . . . 73.109999999999999 110.864 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -168.57 0.28 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.681 2.254 . . . . 55.009999999999998 112.349 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -78.56 -170.18 1.99 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 72.040000000000006 110.954 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.85 29.43 13.48 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.792 -0.718 . . . . 52.219999999999999 112.467 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.12 157.83 29.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.868 0.366 . . . . 75.319999999999993 110.921 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.42 126.82 33.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.063 -0.517 . . . . 74.299999999999997 110.856 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 2.3 p -144.83 162.43 36.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 63.140000000000001 110.901 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.483 ' HB3' HD13 ' A' ' 26' ' ' ILE . 4.8 p-10 -160.37 -41.62 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 73.239999999999995 110.881 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.48 162.56 1.46 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.742 -0.742 . . . . 60.5 112.529 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.19 -37.62 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.763 0.316 . . . . 73.319999999999993 111.111 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.8 pp -68.99 -24.43 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 71.409999999999997 111.127 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -151.29 137.59 18.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 71.150000000000006 110.881 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -174.1 -168.7 0.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.118 -0.492 . . . . 64.329999999999998 110.885 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 95.6 m -50.67 146.19 5.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 73.340000000000003 110.864 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -85.92 -168.07 2.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 70.25 110.909 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.468 ' CB ' ' HA ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -100.03 164.6 16.12 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.643 0.735 . . . . 71.430000000000007 110.874 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.468 ' HA ' ' CB ' ' A' ' 17' ' ' ASP . 54.2 Cg_endo -69.81 -13.21 12.46 Favored 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.672 -1.803 . . . . 63.310000000000002 112.385 0.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -45.29 155.02 0.14 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 75.519999999999996 110.938 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -150.33 129.35 12.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.068 -0.514 . . . . 72.430000000000007 110.824 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 87.9 m -69.5 109.08 4.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 74.150000000000006 110.843 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.48 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 99.5 m -123.69 125.43 25.97 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.582 0.706 . . . . 70.129999999999995 111.174 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.1 Cg_endo -69.78 155.58 93.23 Favored 'Cis proline' 0 C--N 1.342 0.223 0 C-N-CA 122.655 -1.81 . . . . 64.530000000000001 112.361 -0.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 67.97 1.73 Allowed 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.726 2.284 . . . . 75.420000000000002 112.302 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.8 -34.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 74.230000000000004 110.882 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.483 HD13 ' HB3' ' A' ' 9' ' ' ASP . 4.5 tp 179.87 115.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.235 -0.439 . . . . 71.120000000000005 111.159 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.449 ' O ' HD13 ' A' ' 28' ' ' ILE . . . 167.03 -125.84 1.37 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.713 -0.756 . . . . 63.140000000000001 112.435 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 27' ' ' GLY . 11.9 mm -121.1 159.03 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.872 0.367 . . . . 74.200000000000003 111.151 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 75.0 m -95.63 136.45 36.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 65.349999999999994 110.886 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.595 HD22 ' O ' ' A' ' 29' ' ' CYS . 3.5 mm? . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 74.0 110.928 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.86 0.362 . . . . 54.32 110.786 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -106.46 158.09 33.48 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.633 0.73 . . . . 74.150000000000006 110.819 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 -168.87 0.29 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.695 2.263 . . . . 72.109999999999999 112.377 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.405 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 16.4 p90 -80.37 -169.33 2.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 71.310000000000002 110.892 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.6 27.38 18.52 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.747 -0.74 . . . . 72.329999999999998 112.486 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -119.29 154.01 34.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.862 0.363 . . . . 73.340000000000003 110.91 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.79 142.27 28.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.491 . . . . 70.420000000000002 110.807 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.62 161.83 38.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 54.200000000000003 110.949 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -150.8 -41.46 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 74.5 110.892 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.4 170.5 0.32 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.812 -0.709 . . . . 44.350000000000001 112.453 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 p -112.31 -39.56 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 72.409999999999997 111.145 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.443 HD12 ' H ' ' A' ' 12' ' ' ILE . 3.9 mp -61.95 -70.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 72.140000000000001 111.175 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -126.21 147.26 49.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 55.32 110.93 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -162.94 -76.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 74.349999999999994 110.844 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.1 m -121.76 143.15 49.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 73.420000000000002 110.92 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.69 -169.93 1.92 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 74.129999999999995 110.925 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.469 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -106.89 164.69 14.3 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.563 0.697 . . . . 71.219999999999999 110.914 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.469 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.87 -11.66 12.17 Favored 'Cis proline' 0 C--O 1.232 0.175 0 C-N-CA 122.634 -1.819 . . . . 73.530000000000001 112.353 0.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -42.38 151.95 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 75.400000000000006 110.876 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -150.53 132.72 15.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.021 -0.536 . . . . 75.329999999999998 110.865 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.1 m -69.54 112.96 6.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 71.120000000000005 110.891 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.4 m -121.56 117.05 30.33 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.603 0.716 . . . . 74.519999999999996 111.129 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 169.34 63.86 Favored 'Cis proline' 0 C--N 1.342 0.205 0 C-N-CA 122.627 -1.822 . . . . 73.329999999999998 112.363 -0.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.75 -7.21 20.48 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.692 2.261 . . . . 53.450000000000003 112.325 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -94.01 -53.22 4.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.268 -0.424 . . . . 62.149999999999999 110.93 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.6 tt -165.33 125.07 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 74.0 111.183 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.41 -124.97 1.12 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.817 -0.706 . . . . 73.230000000000004 112.527 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.15 170.19 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.88 0.372 . . . . 62.409999999999997 111.109 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.641 ' O ' HD22 ' A' ' 30' ' ' LEU . 66.4 m -100.13 130.38 46.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 65.140000000000001 110.955 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.641 HD22 ' O ' ' A' ' 29' ' ' CYS . 3.9 mm? . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 75.340000000000003 110.938 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.813 0.339 . . . . 72.200000000000003 110.933 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -105.24 153.34 39.67 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.597 0.713 . . . . 74.25 110.847 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -169.08 0.31 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.688 2.259 . . . . 73.439999999999998 112.311 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -78.83 -170.64 2.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 73.439999999999998 110.9 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 50.23 28.55 13.86 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.708 -0.758 . . . . 53.240000000000002 112.497 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.58 155.26 34.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.855 0.359 . . . . 75.540000000000006 110.888 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -83.6 124.39 30.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 74.329999999999998 110.904 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.8 p -135.12 153.82 51.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 71.099999999999994 110.937 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -167.25 125.48 1.29 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 72.400000000000006 110.887 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.2 -133.18 6.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.655 -0.784 . . . . 71.530000000000001 112.486 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.6 p -169.53 -37.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.809 0.338 . . . . 64.239999999999995 111.171 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.42 HG23 ' N ' ' A' ' 13' ' ' ASN . 5.1 tt -51.93 -44.97 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 72.329999999999998 111.127 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.42 ' N ' HG23 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -153.56 152.95 31.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 60.25 110.825 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -174.34 -167.09 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 74.439999999999998 110.965 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 96.8 m -49.62 146.45 4.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.303 -0.408 . . . . 74.510000000000005 110.853 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.25 -167.9 2.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.310000000000002 110.87 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.469 ' CB ' ' HA ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -99.68 164.7 16.06 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.573 0.701 . . . . 53.43 110.823 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.469 ' HA ' ' CB ' ' A' ' 17' ' ' ASP . 54.0 Cg_endo -69.65 -13.31 12.16 Favored 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.712 -1.787 . . . . 75.230000000000004 112.391 -0.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -45.46 155.22 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 74.420000000000002 110.898 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -150.21 129.66 12.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 64.439999999999998 110.909 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 67.2 m -70.03 111.38 5.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 73.349999999999994 110.945 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.467 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 80.4 m -122.62 124.11 26.8 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.604 0.716 . . . . 52.420000000000002 111.121 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.6 Cg_endo -69.72 157.63 91.76 Favored 'Cis proline' 0 C--N 1.342 0.189 0 C-N-CA 122.701 -1.791 . . . . 65.019999999999996 112.368 -0.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 64.04 1.79 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.722 2.282 . . . . 65.329999999999998 112.337 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -175.83 -36.09 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 64.140000000000001 110.882 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 26' ' ' ILE . 1.3 tt -178.43 116.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.266 -0.425 . . . . 74.239999999999995 111.144 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.61 -126.68 1.46 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.795 -0.717 . . . . 41.240000000000002 112.545 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 29' ' ' CYS . 10.8 mm -117.62 159.32 17.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.875 0.369 . . . . 55.439999999999998 111.122 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 78.1 m -96.38 134.03 40.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 61.43 110.912 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.594 HD22 ' O ' ' A' ' 29' ' ' CYS . 3.3 mm? . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 73.319999999999993 110.931 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.811 0.339 . . . . 74.510000000000005 110.95 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.78 157.58 33.62 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.59 0.71 . . . . 62.530000000000001 110.868 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -168.58 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.692 2.261 . . . . 74.200000000000003 112.31 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -80.0 -170.82 2.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 71.219999999999999 110.932 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 50.87 27.9 14.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.781 -0.723 . . . . 75.400000000000006 112.466 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -120.24 153.08 36.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.836 0.351 . . . . 75.120000000000005 110.907 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.77 137.99 35.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.505 . . . . 71.040000000000006 110.897 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.1 p -150.75 155.88 40.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 72.25 110.867 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.73 117.78 4.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 71.129999999999995 110.859 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.05 -130.61 5.38 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.695 -0.764 . . . . 30.120000000000001 112.474 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -176.81 -35.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 75.510000000000005 111.082 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.466 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -57.69 -26.59 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 70.510000000000005 111.094 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -179.74 133.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 74.519999999999996 110.866 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.49 -77.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 65.450000000000003 110.922 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.3 m -120.85 149.15 43.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 53.350000000000001 110.873 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.23 -169.29 2.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 74.109999999999999 110.809 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.468 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -106.7 164.54 14.65 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.611 0.719 . . . . 45.310000000000002 110.858 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.468 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.66 -11.92 11.85 Favored 'Cis proline' 0 C--N 1.342 0.21 0 C-N-CA 122.71 -1.787 . . . . 73.129999999999995 112.356 -0.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -42.26 152.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 65.129999999999995 110.898 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -150.72 130.51 13.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 72.120000000000005 110.863 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 60.2 m -70.54 114.69 8.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 74.420000000000002 110.819 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.463 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 98.4 m -123.84 123.36 26.24 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.539 0.685 . . . . 74.019999999999996 111.182 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.463 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.81 158.07 91.55 Favored 'Cis proline' 0 C--N 1.341 0.163 0 C-N-CA 122.627 -1.822 . . . . 72.409999999999997 112.358 0.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 64.44 1.79 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.706 2.27 . . . . 74.239999999999995 112.297 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -177.2 -34.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 74.420000000000002 110.861 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.455 ' O ' HG23 ' A' ' 26' ' ' ILE . 4.7 tt -176.88 107.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 72.420000000000002 111.16 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 176.46 -132.31 2.05 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.661 -0.78 . . . . 74.420000000000002 112.442 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 29' ' ' CYS . 12.1 mm -116.06 158.87 16.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.869 0.366 . . . . 51.210000000000001 111.162 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.625 ' O ' HD22 ' A' ' 30' ' ' LEU . 79.3 m -90.6 132.46 35.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 54.140000000000001 110.898 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.625 HD22 ' O ' ' A' ' 29' ' ' CYS . 3.7 mm? . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 65.030000000000001 110.885 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.785 0.326 . . . . 73.120000000000005 110.907 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -110.46 157.96 36.74 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.598 0.713 . . . . 73.310000000000002 110.907 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -167.14 0.21 Allowed 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.734 2.289 . . . . 65.439999999999998 112.351 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -82.03 178.23 8.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 52.340000000000003 110.945 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.33 13.25 53.83 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.689 -0.767 . . . . 74.019999999999996 112.514 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -101.82 172.76 6.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.875 0.369 . . . . 74.209999999999994 110.942 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.22 125.86 43.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 70.040000000000006 110.954 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.96 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.2 p -132.94 168.62 18.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 61.299999999999997 110.901 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -157.2 -42.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 73.040000000000006 110.812 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.81 173.1 0.88 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.827 -0.702 . . . . 65.420000000000002 112.459 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.6 m -121.29 -7.64 9.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.874 0.369 . . . . 64.019999999999996 111.11 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.2 pp -115.73 -24.29 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 52.310000000000002 111.147 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.45 120.4 7.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 72.219999999999999 110.86 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -163.07 -78.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 63.420000000000002 110.883 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.8 m -122.45 134.11 54.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 73.420000000000002 110.858 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.07 -177.08 2.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 75.109999999999999 110.892 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.481 ' CB ' ' HA ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -101.38 165.05 14.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.655 0.741 . . . . 73.239999999999995 110.823 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.481 ' HA ' ' CB ' ' A' ' 17' ' ' ASP . 53.9 Cg_endo -69.75 -12.09 12.06 Favored 'Cis proline' 0 C--N 1.342 0.217 0 C-N-CA 122.693 -1.794 . . . . 74.329999999999998 112.362 0.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -47.73 159.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 72.340000000000003 110.931 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -143.95 -169.98 3.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.507 . . . . 74.340000000000003 110.899 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.521 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 44.9 m -125.1 119.09 27.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 64.109999999999999 110.84 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.465 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 88.5 m -129.19 124.17 22.07 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.564 0.697 . . . . 70.109999999999999 111.14 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.465 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.74 159.53 89.47 Favored 'Cis proline' 0 C--O 1.232 0.193 0 C-N-CA 122.68 -1.8 . . . . 71.120000000000005 112.341 -0.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 63.74 1.82 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.678 2.252 . . . . 74.030000000000001 112.338 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.598 HD13 ' O ' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -175.48 -39.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 70.219999999999999 110.916 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.4 tt -177.97 127.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 73.530000000000001 111.075 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.03 -124.65 1.55 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.732 -0.747 . . . . 61.219999999999999 112.438 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.2 mm -114.81 152.39 16.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 73.120000000000005 111.205 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.96 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 71.6 m -93.4 158.83 15.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 73.150000000000006 110.876 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 63.240000000000002 110.928 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.789 0.328 . . . . 55.539999999999999 110.86 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -107.18 161.58 22.49 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.581 0.705 . . . . 75.349999999999994 110.933 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.74 -91.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.681 2.254 . . . . 72.409999999999997 112.31 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 6.5 p90 -155.15 -166.95 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 73.230000000000004 110.902 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.63 24.09 11.46 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.791 -0.718 . . . . 65.400000000000006 112.531 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -116.01 150.91 36.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.85 0.357 . . . . 75.099999999999994 110.953 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.65 138.2 36.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 73.450000000000003 110.862 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 p -144.31 161.88 37.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 74.140000000000001 110.923 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -154.99 -41.66 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 71.200000000000003 110.832 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.41 150.79 19.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 64.140000000000001 112.525 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.4 p -94.33 -31.45 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.767 0.317 . . . . 72.349999999999994 111.088 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.4 mp -63.88 -69.18 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 75.129999999999995 111.167 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -129.83 151.66 50.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 71.140000000000001 110.829 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.91 -76.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 72.129999999999995 110.927 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.2 m -123.01 149.23 44.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.443 . . . . 72.200000000000003 110.829 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.24 -168.38 2.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.489 . . . . 42.32 110.864 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.472 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -107.98 164.07 15.57 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.56 0.695 . . . . 73.540000000000006 110.893 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.472 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.76 -11.12 11.8 Favored 'Cis proline' 0 C--N 1.341 0.172 0 C-N-CA 122.676 -1.802 . . . . 72.420000000000002 112.363 0.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -41.69 152.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 74.519999999999996 110.899 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -151.35 129.19 11.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 75.209999999999994 110.901 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.45 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 36.3 m -70.62 114.61 8.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 75.010000000000005 110.868 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.406 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 68.0 m -119.25 118.98 32.23 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.562 0.696 . . . . 74.150000000000006 111.115 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.406 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.9 Cg_endo -69.73 168.66 66.57 Favored 'Cis proline' 0 C--N 1.341 0.177 0 C-N-CA 122.676 -1.802 . . . . 72.129999999999995 112.406 -0.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -7.57 21.38 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.699 2.266 . . . . 75.530000000000001 112.375 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.51 HD13 ' O ' ' A' ' 25' ' ' LEU . 0.9 OUTLIER -93.58 -44.74 8.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 51.409999999999997 111.006 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.404 HG23 ' O ' ' A' ' 26' ' ' ILE . 8.6 tt -174.6 123.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 61.219999999999999 111.127 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.42 -131.57 2.11 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.69 -0.767 . . . . 53.399999999999999 112.5 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 29' ' ' CYS . 12.2 mt -113.26 158.53 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 63.420000000000002 111.097 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.635 ' O ' HD22 ' A' ' 30' ' ' LEU . 80.8 m -90.81 130.82 36.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 73.150000000000006 110.888 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.635 HD22 ' O ' ' A' ' 29' ' ' CYS . 3.0 mm? . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 73.129999999999995 110.898 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.844 0.354 . . . . 72.209999999999994 110.883 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -95.52 150.42 37.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.579 0.704 . . . . 55.43 110.858 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.81 -166.22 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.677 2.251 . . . . 65.439999999999998 112.334 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -80.97 176.23 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 75.010000000000005 110.969 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.09 7.78 57.31 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.751 -0.738 . . . . 31.550000000000001 112.5 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.34 -172.93 2.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 74.319999999999993 110.906 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -114.37 135.12 54.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 74.540000000000006 110.881 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 1.034 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -136.79 171.07 15.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 75.5 110.841 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -160.29 -42.4 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 73.120000000000005 110.884 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.03 153.6 50.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.686 -0.769 . . . . 22.32 112.518 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.43 HG13 HG23 ' A' ' 12' ' ' ILE . 10.8 p -90.93 -34.44 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.884 0.373 . . . . 62.149999999999999 111.15 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.43 HG23 HG13 ' A' ' 11' ' ' VAL . 1.3 pp -87.95 -25.41 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 74.25 111.084 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -128.27 113.18 15.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 71.129999999999995 110.879 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -174.25 -168.22 0.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 61.210000000000001 110.905 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 74.6 m -48.02 147.31 2.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 73.150000000000006 110.889 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.77 -167.62 1.73 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 71.319999999999993 110.873 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -100.41 163.44 18.21 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.654 0.74 . . . . 75.420000000000002 110.859 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.75 -12.17 12.1 Favored 'Cis proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.715 -1.785 . . . . 61.420000000000002 112.364 -0.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -44.65 155.34 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 64.510000000000005 110.988 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -146.24 127.87 15.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 74.129999999999995 110.82 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.536 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 55.5 m -60.53 122.67 15.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 63.229999999999997 110.888 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 22' ' ' THR . 5.9 t -121.51 116.22 30.76 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.578 0.704 . . . . 64.329999999999998 111.129 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 168.23 68.47 Favored 'Cis proline' 0 C--N 1.342 0.213 0 C-N-CA 122.644 -1.815 . . . . 62.420000000000002 112.382 -0.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 63.28 1.76 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.679 2.253 . . . . 75.420000000000002 112.356 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.451 HD12 HG22 ' A' ' 26' ' ' ILE . 2.6 tm? -174.69 -67.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.424 . . . . 73.140000000000001 110.927 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.451 HG22 HD12 ' A' ' 25' ' ' LEU . 17.7 tt -149.75 141.92 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 74.219999999999999 111.139 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.419 ' C ' HD13 ' A' ' 28' ' ' ILE . . . 136.9 -112.89 0.98 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.723 -0.751 . . . . 74.450000000000003 112.548 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.498 HG22 ' H ' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -110.33 -172.91 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 70.430000000000007 111.146 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 1.034 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 41.3 m -136.58 150.51 48.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 64.099999999999994 110.887 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 74.530000000000001 110.884 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.822 0.344 . . . . 45.409999999999997 110.869 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -109.77 157.71 36.86 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.696 0.76 . . . . 62.43 110.81 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -166.87 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.659 2.239 . . . . 75.329999999999998 112.36 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -85.45 179.25 7.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 64.040000000000006 110.944 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.94 12.33 54.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.689 -0.767 . . . . 43.420000000000002 112.449 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.84 168.73 8.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.93 0.395 . . . . 74.519999999999996 110.893 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.05 146.96 23.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.07 -0.514 . . . . 64.319999999999993 110.766 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.828 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -150.16 156.45 41.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 51.520000000000003 110.878 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -141.6 -42.16 0.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 74.049999999999997 110.9 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.05 -179.6 0.41 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.688 -0.768 . . . . 51.149999999999999 112.493 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.8 p -128.29 -39.42 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 63.229999999999997 111.125 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.464 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -73.84 -25.77 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 73.540000000000006 111.119 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.01 132.22 8.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 74.120000000000005 110.92 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -165.07 -76.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 74.140000000000001 110.949 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 m -120.87 134.33 55.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 63.229999999999997 110.893 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.99 -167.54 0.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 44.340000000000003 110.83 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.484 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -111.85 162.85 19.36 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.604 0.716 . . . . 51.420000000000002 110.858 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.73 -9.16 10.81 Favored 'Cis proline' 0 C--N 1.343 0.238 0 C-N-CA 122.674 -1.803 . . . . 73.129999999999995 112.327 -0.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -40.33 151.42 0.05 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.26 -0.427 . . . . 72.5 110.926 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -150.37 132.6 15.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 71.510000000000005 110.811 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.579 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 65.7 m -69.18 121.39 16.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 52.350000000000001 110.867 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.412 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 54.7 m -123.93 118.25 27.0 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.633 0.73 . . . . 72.530000000000001 111.091 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.412 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.83 164.05 80.44 Favored 'Cis proline' 0 C--N 1.342 0.202 0 C-N-CA 122.686 -1.797 . . . . 61.509999999999998 112.342 -0.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 63.09 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.648 2.232 . . . . 73.420000000000002 112.364 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.591 HD13 HG13 ' A' ' 26' ' ' ILE . 2.0 tm? -174.97 -68.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 61.530000000000001 110.95 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.591 HG13 HD13 ' A' ' 25' ' ' LEU . 27.8 mt -142.84 114.39 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 75.439999999999998 111.114 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.27 -128.84 1.82 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.71 -0.757 . . . . 72.319999999999993 112.447 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.4 HG22 ' H ' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -106.5 -170.83 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.893 0.377 . . . . 74.439999999999998 111.134 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.828 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 58.1 m -130.47 149.63 52.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.472 . . . . 65.439999999999998 110.879 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.467 . . . . 64.340000000000003 110.851 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.841 0.353 . . . . 72.310000000000002 110.911 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -105.67 159.32 29.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.644 0.735 . . . . 74.420000000000002 110.848 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -90.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.707 2.272 . . . . 53.229999999999997 112.316 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.42 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 17.0 p90 -153.7 -164.5 1.9 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 75.140000000000001 110.998 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.34 27.13 15.55 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.697 -0.763 . . . . 74.409999999999997 112.481 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -125.34 155.09 40.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.892 0.377 . . . . 72.129999999999995 110.959 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -79.71 124.22 28.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 63.439999999999998 110.923 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.765 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.8 p -131.24 146.51 52.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 65.540000000000006 110.832 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -134.02 -44.54 0.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.103 -0.499 . . . . 74.209999999999994 110.878 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.53 149.83 7.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.796 -0.716 . . . . 74.109999999999999 112.501 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.13 -20.98 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 61.43 111.102 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 13' ' ' ASN . 5.5 tt -115.86 -44.57 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 70.230000000000004 111.117 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.425 ' N ' HG23 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -92.14 99.08 11.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 73.120000000000005 110.914 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -169.06 -167.06 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 72.019999999999996 110.912 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 80.5 m -49.77 133.18 21.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 72.409999999999997 110.823 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -79.03 -169.05 1.66 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 75.439999999999998 110.847 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.498 ' CB ' ' HA ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -94.4 165.94 16.42 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.583 0.706 . . . . 73.219999999999999 110.838 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.498 ' HA ' ' CB ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.73 -14.08 12.39 Favored 'Cis proline' 0 C--N 1.341 0.133 0 C-N-CA 122.682 -1.799 . . . . 60.210000000000001 112.4 -0.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -44.14 156.95 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 72.219999999999999 110.946 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -148.67 130.22 14.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 73.219999999999999 110.784 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.568 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 57.9 m -71.89 113.05 8.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.467 . . . . 54.009999999999998 110.902 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.411 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 66.9 m -119.38 118.33 32.5 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.551 0.691 . . . . 64.340000000000003 111.151 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.462 ' HD2' ' HA3' ' A' ' 27' ' ' GLY . 53.6 Cg_endo -69.76 170.44 58.48 Favored 'Cis proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.699 -1.792 . . . . 75.310000000000002 112.337 -0.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 -5.95 17.41 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.727 2.285 . . . . 70.010000000000005 112.381 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.6 -66.26 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 53.32 110.905 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.5 mt -151.72 128.1 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 60.520000000000003 111.119 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.462 ' HA3' ' HD2' ' A' ' 23' ' ' PRO . . . 166.32 -132.03 2.53 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.691 -0.766 . . . . 74.519999999999996 112.449 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.485 HG22 ' H ' ' A' ' 29' ' ' CYS . 3.0 mm -110.35 167.32 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.872 0.368 . . . . 74.049999999999997 111.16 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.765 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 86.7 m -104.98 134.63 47.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 50.25 110.848 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.625 HD22 ' O ' ' A' ' 29' ' ' CYS . 2.5 mm? . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 63.109999999999999 110.893 179.962 . . . . . . . . 1 1 . 1 stop_ save_